Advancing the global public health agenda for NAFLD: a consensus statement
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hep...
Uloženo v:
| Vydáno v: | Nature reviews. Gastroenterology & hepatology Ročník 19; číslo 1; s. 60 - 78 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
01.01.2022
Nature Publishing Group |
| Témata: | |
| ISSN: | 1759-5045, 1759-5053, 1759-5053 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD.
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action. |
|---|---|
| AbstractList | Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD.Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics - from epidemiology, awareness, care and treatment to public health policies and leadership - that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics — from epidemiology, awareness, care and treatment to public health policies and leadership — that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action. Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics - from epidemiology, awareness, care and treatment to public health policies and leadership - that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD.Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It is a multisystem disease and is considered the hepatic component of metabolic syndrome. Unlike other highly prevalent conditions, NAFLD has received little attention from the global public health community. Health system and public health responses to NAFLD have been weak and fragmented, and, despite its pervasiveness, NAFLD is largely unknown outside hepatology and gastroenterology. There is only a nascent global public health movement addressing NAFLD, and the disease is absent from nearly all national and international strategies and policies for non-communicable diseases, including obesity. In this global Delphi study, a multidisciplinary group of experts developed consensus statements and recommendations, which a larger group of collaborators reviewed over three rounds until consensus was achieved. The resulting consensus statements and recommendations address a broad range of topics - from epidemiology, awareness, care and treatment to public health policies and leadership - that have general relevance for policy-makers, health-care practitioners, civil society groups, research institutions and affected populations. These recommendations should provide a strong foundation for a comprehensive public health response to NAFLD. |
| Author | Mark, Henry E. Hagström, Hannes Cortez-Pinto, Helena Sarin, Shiv Kumar Dirac, M. Ashworth Ninburg, Michael Cusi, Kenneth Huang, Terry T.-K. Schattenberg, Jörn M. Castera, Laurent Arab, Juan Pablo Romero-Gómez, Manuel Zelber-Sagi, Shira Yilmaz, Yusuf Newsome, Philip N. Tsochatzis, Emmanuel A. Francque, Sven Miller, Veronica Wong, Vincent Wai-Sun Loomba, Rohit Ratziu, Vlad Anstee, Quentin M. Rinella, Mary Lazarus, Jeffrey V. Crespo, Javier Kautz, Achim Batterham, Rachel L. Ocama, Ponsiano Romero, Diana Valenti, Luca Younossi, Zobair M. George, Jacob Ismail, Mona H. |
| Author_xml | – sequence: 1 givenname: Jeffrey V. orcidid: 0000-0001-9618-2299 surname: Lazarus fullname: Lazarus, Jeffrey V. email: Jeffrey.Lazarus@isglobal.org organization: Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, EASL International Liver Foundation – sequence: 2 givenname: Henry E. orcidid: 0000-0002-8022-4279 surname: Mark fullname: Mark, Henry E. organization: EASL International Liver Foundation – sequence: 3 givenname: Quentin M. orcidid: 0000-0002-9518-0088 surname: Anstee fullname: Anstee, Quentin M. organization: Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust – sequence: 4 givenname: Juan Pablo orcidid: 0000-0002-8561-396X surname: Arab fullname: Arab, Juan Pablo organization: Departamento de Gastroenterologia, Escuela de Medicina, Pontificia Universidad Catolica de Chile – sequence: 5 givenname: Rachel L. surname: Batterham fullname: Batterham, Rachel L. organization: Centre for Obesity Research, University College London and National Institute of Health Research, UCLH Biomedical Research Centre – sequence: 6 givenname: Laurent orcidid: 0000-0002-6715-8588 surname: Castera fullname: Castera, Laurent organization: Department of Hepatology, Hôpital Beaujon, Université de Paris – sequence: 7 givenname: Helena orcidid: 0000-0002-8537-8744 surname: Cortez-Pinto fullname: Cortez-Pinto, Helena organization: Clínica Universitária de Gastrenterologia, Laboratório de Nutrição, Faculdade de Medicina, Universidade de Lisboa – sequence: 8 givenname: Javier orcidid: 0000-0001-8248-0172 surname: Crespo fullname: Crespo, Javier organization: Gastroenterology and Heptology Unit, Hospital Universitario Marqués de Valdecilla, Santander, IDIVAL – sequence: 9 givenname: Kenneth surname: Cusi fullname: Cusi, Kenneth organization: Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Veterans Health Administration and University of Florida – sequence: 10 givenname: M. Ashworth surname: Dirac fullname: Dirac, M. Ashworth organization: Department of Health Metrics Sciences, Department of Family Medicine, University of Washington – sequence: 11 givenname: Sven orcidid: 0000-0002-7527-4714 surname: Francque fullname: Francque, Sven organization: Department of Gastroenterology Hepatology, University Hospital Antwerp, Translational Sciences in Inflammation and Immunology TWI2N, Faculty of Medicine and Health Sciences, University of Antwerp – sequence: 12 givenname: Jacob orcidid: 0000-0002-8421-5476 surname: George fullname: George, Jacob organization: Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney – sequence: 13 givenname: Hannes surname: Hagström fullname: Hagström, Hannes organization: Department of Medicine, Karolinska Institutet – sequence: 14 givenname: Terry T.-K. orcidid: 0000-0001-5544-5187 surname: Huang fullname: Huang, Terry T.-K. organization: Center for Systems and Community Design and NYU-CUNY Prevention Research Center, Graduate School of Public Health and Health Policy, City University of New York – sequence: 15 givenname: Mona H. orcidid: 0000-0001-6371-3997 surname: Ismail fullname: Ismail, Mona H. organization: Division of Gastroenterology, Department of Internal Medicine, King Fahd Hospital of the University, College of Medicine, Imam Abdulrahman Bin Faisal University – sequence: 16 givenname: Achim surname: Kautz fullname: Kautz, Achim organization: Kautz5 – sequence: 17 givenname: Shiv Kumar orcidid: 0000-0002-0544-5610 surname: Sarin fullname: Sarin, Shiv Kumar organization: Department of Hepatology, Institute of Liver and Biliary Sciences – sequence: 18 givenname: Rohit orcidid: 0000-0002-4845-9991 surname: Loomba fullname: Loomba, Rohit organization: Department of Medicine, NAFLD Research Center, Department of Medicine, University of California San Diego – sequence: 19 givenname: Veronica surname: Miller fullname: Miller, Veronica organization: University of California Berkeley, School of Public Health, Forum for Collaborative Research – sequence: 20 givenname: Philip N. surname: Newsome fullname: Newsome, Philip N. organization: National Institute for Health Research Birmingham Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham – sequence: 21 givenname: Michael orcidid: 0000-0001-8592-5878 surname: Ninburg fullname: Ninburg, Michael organization: Hepatitis Education Project – sequence: 22 givenname: Ponsiano surname: Ocama fullname: Ocama, Ponsiano organization: Department of Medicine, College of Health Sciences, Makerere University – sequence: 23 givenname: Vlad surname: Ratziu fullname: Ratziu, Vlad organization: Assistance Publique-Hôpitaux de Paris, Hôpital Pitie-Salpetriere, University of Paris – sequence: 24 givenname: Mary surname: Rinella fullname: Rinella, Mary organization: Department of Medicine, Feinberg School of Medicine, Northwestern University – sequence: 25 givenname: Diana orcidid: 0000-0002-4832-9564 surname: Romero fullname: Romero, Diana organization: Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy – sequence: 26 givenname: Manuel orcidid: 0000-0001-8494-8947 surname: Romero-Gómez fullname: Romero-Gómez, Manuel organization: UCM Digestive Diseases, CIBEREHD and IBIS, Virgen del Rocío University Hospital, University of Seville – sequence: 27 givenname: Jörn M. orcidid: 0000-0002-4224-4703 surname: Schattenberg fullname: Schattenberg, Jörn M. organization: Metabolic Liver Research Program, I. Department of Medicine, University Medical Centre Mainz – sequence: 28 givenname: Emmanuel A. surname: Tsochatzis fullname: Tsochatzis, Emmanuel A. organization: University College London Institute for Liver and Digestive Health, Royal Free Hospital, Sheila Sherlock Liver Centre, Royal Free Hospital – sequence: 29 givenname: Luca surname: Valenti fullname: Valenti, Luca organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Precision Medicine, Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico – sequence: 30 givenname: Vincent Wai-Sun orcidid: 0000-0003-2215-9410 surname: Wong fullname: Wong, Vincent Wai-Sun organization: Department of Medicine and Therapeutics, The Chinese University of Hong Kong – sequence: 31 givenname: Yusuf orcidid: 0000-0003-4518-5283 surname: Yilmaz fullname: Yilmaz, Yusuf organization: Department of Gastroenterology, Marmara University School of Medicine, Liver Research Unit, Institute of Gastroenterology, Marmara University – sequence: 32 givenname: Zobair M. surname: Younossi fullname: Younossi, Zobair M. organization: Center for Liver Diseases, Inova Medicine – sequence: 33 givenname: Shira surname: Zelber-Sagi fullname: Zelber-Sagi, Shira organization: University of Haifa, Faculty of Social Welfare and Health Sciences, School of Public Health, Mount Carmel, Department of Gastroenterology, Tel-Aviv Medical Centre |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34707258$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:148057598$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNp9kU1P3DAQhi0E4mPhD_RQWeqFS8o4tuOktxWFFrSCC5wtx5nshmbtrZ0U8e_rZZdF4oBka0ajZzyv3zkh-847JOQLg-8MeHkRBZNKZpCzDEDmPBN75JgpWWUSJN_f5UIekZMYnwAKKXl1SI64UKByWR6T22nzzzjbuTkdFkjnva9NT1dj3XeWLtD0w4KaObrG0NYHeje9nv38QQ213kV0cYw0DmbAJbrhlBy0po94to0T8nh99XD5O5vd_7q5nM4yK0U1ZNxCg6ys0jVmfVQtlcAaeVsJIxHA1qkqeVLIGbKirvJKctEUbVsYC3xCss278RmTUL0K3dKEF-1Np7elPylDLWQJIBJ_vuFXwf8dMQ562UWLfW8c-jHq5INSvMxf0W8f0Cc_Bpd-o_OCcQAlUpiQr1tqrJfY7AS8uZqAfAPY4GMM2O4QBnq9Or1ZnU6r06-r0-vZ5Ycm2yVrO--GYLr-81a-dSTNcXMM77I_6foPaGarig |
| CitedBy_id | crossref_primary_10_1007_s10620_023_08094_x crossref_primary_10_1111_eci_14123 crossref_primary_10_3389_fnut_2024_1487859 crossref_primary_10_1186_s12913_022_07808_7 crossref_primary_10_3390_biomedicines11041097 crossref_primary_10_1016_j_aohep_2025_101898 crossref_primary_10_1007_s12072_023_10576_z crossref_primary_10_1108_IJHG_09_2023_0087 crossref_primary_10_1038_s41598_023_45828_3 crossref_primary_10_1089_jmf_2022_0100 crossref_primary_10_1002_ar_25039 crossref_primary_10_1080_10408398_2023_2204349 crossref_primary_10_3390_genes14030553 crossref_primary_10_1016_j_freeradbiomed_2025_06_042 crossref_primary_10_1016_j_phrs_2023_106679 crossref_primary_10_3389_fimmu_2023_1077041 crossref_primary_10_1016_j_pharmthera_2022_108334 crossref_primary_10_1038_s41392_024_02072_z crossref_primary_10_3390_ijms25136839 crossref_primary_10_7717_peerj_15225 crossref_primary_10_1111_cpr_13576 crossref_primary_10_1186_s41043_025_01015_w crossref_primary_10_1039_D3FO03572G crossref_primary_10_1038_s41598_025_85508_y crossref_primary_10_1002_ijgo_70374 crossref_primary_10_3390_ijms252313067 crossref_primary_10_1016_j_aohep_2023_101085 crossref_primary_10_1038_s44355_025_00025_z crossref_primary_10_1038_s41598_025_96478_6 crossref_primary_10_1038_s44318_024_00196_0 crossref_primary_10_1021_acsomega_4c10956 crossref_primary_10_1038_s41575_023_00818_8 crossref_primary_10_59717_j_xinn_med_2024_100064 crossref_primary_10_1038_s41467_024_47919_9 crossref_primary_10_3390_antiox12061212 crossref_primary_10_1097_MCO_0000000000000960 crossref_primary_10_1016_j_cmet_2022_09_014 crossref_primary_10_1002_hep_32774 crossref_primary_10_1124_pharmrev_123_001087 crossref_primary_10_1016_j_cmet_2022_09_017 crossref_primary_10_1161_HYPERTENSIONAHA_124_24252 crossref_primary_10_1038_s43856_025_00871_1 crossref_primary_10_1016_j_aohep_2022_100873 crossref_primary_10_3390_livers3010001 crossref_primary_10_4103_ATMR_ATMR_78_24 crossref_primary_10_4178_epih_e2024024 crossref_primary_10_3390_md23020063 crossref_primary_10_1016_j_cegh_2024_101858 crossref_primary_10_3389_fpubh_2023_1231240 crossref_primary_10_3390_medicina59091614 crossref_primary_10_1016_S0140_6736_22_01200_4 crossref_primary_10_1038_s41574_023_00807_6 crossref_primary_10_1002_hep4_2066 crossref_primary_10_3390_biology12121480 crossref_primary_10_2147_DMSO_S407511 crossref_primary_10_3390_cells12071022 crossref_primary_10_1016_j_lfs_2023_121595 crossref_primary_10_1093_eurheartj_ehac029 crossref_primary_10_1007_s11901_023_00628_1 crossref_primary_10_1017_S1092852922001043 crossref_primary_10_14309_ctg_0000000000000680 crossref_primary_10_1002_ame2_12338 crossref_primary_10_1136_gutjnl_2025_335542 crossref_primary_10_1001_jamainternmed_2025_1809 crossref_primary_10_1016_j_medj_2024_07_013 crossref_primary_10_1016_S0140_6736_25_01091_8 crossref_primary_10_1055_s_0042_1759544 crossref_primary_10_1097_MEG_0000000000003077 crossref_primary_10_1007_s10654_025_01224_x crossref_primary_10_1016_j_jep_2025_119801 crossref_primary_10_1002_hep4_2082 crossref_primary_10_3389_fnut_2025_1540903 crossref_primary_10_1016_j_intimp_2024_113641 crossref_primary_10_1002_mnfr_70134 crossref_primary_10_1186_s12913_023_10537_0 crossref_primary_10_3390_nu16111586 crossref_primary_10_1016_S2468_1253_22_00049_8 crossref_primary_10_1007_s12672_025_03276_7 crossref_primary_10_1111_jgh_17009 crossref_primary_10_1016_j_aohep_2024_101584 crossref_primary_10_3390_ijms242216141 crossref_primary_10_3390_diagnostics13040788 crossref_primary_10_1016_j_medcli_2022_07_010 crossref_primary_10_1016_j_jhep_2023_03_014 crossref_primary_10_1016_j_envpol_2025_126570 crossref_primary_10_1016_j_hbpd_2023_09_003 crossref_primary_10_1186_s43044_024_00462_w crossref_primary_10_3390_ijms25031721 crossref_primary_10_1016_S2468_1253_23_00270_4 crossref_primary_10_3390_ijerph19063268 crossref_primary_10_3748_wjg_v29_i12_1765 crossref_primary_10_1111_liv_16112 crossref_primary_10_1186_s12876_024_03229_4 crossref_primary_10_1016_j_metabol_2024_156055 crossref_primary_10_1016_j_eprac_2024_08_002 crossref_primary_10_1016_j_gtc_2023_03_008 crossref_primary_10_1590_1806_9282_20231537 crossref_primary_10_1038_s43856_022_00228_y crossref_primary_10_1111_jcmm_70500 crossref_primary_10_3233_CH_238102 crossref_primary_10_1016_j_jhep_2023_04_036 crossref_primary_10_1016_j_jhep_2023_04_035 crossref_primary_10_1093_ejendo_lvae050 crossref_primary_10_1002_ptr_70049 crossref_primary_10_1007_s00125_022_05787_2 crossref_primary_10_1007_s12072_023_10543_8 crossref_primary_10_1016_j_jhep_2023_04_037 crossref_primary_10_1002_jpn3_12399 crossref_primary_10_1016_j_aohep_2024_101562 crossref_primary_10_1515_biol_2022_0699 crossref_primary_10_1186_s12866_025_03849_0 crossref_primary_10_3389_fnut_2024_1415484 crossref_primary_10_1016_j_cell_2024_03_034 crossref_primary_10_26724_2079_8334_2025_1_91_101_105 crossref_primary_10_1016_j_jare_2025_07_048 crossref_primary_10_1097_HEP_0000000000000411 crossref_primary_10_1111_liv_15879 crossref_primary_10_1002_jbmr_4862 crossref_primary_10_3390_nu15030526 crossref_primary_10_3390_nu15030648 crossref_primary_10_1016_j_fufo_2025_100562 crossref_primary_10_1038_s41575_024_00938_9 crossref_primary_10_1097_HEP_0000000000000545 crossref_primary_10_3390_biom12121773 crossref_primary_10_3390_diagnostics14121237 crossref_primary_10_1016_j_biopha_2024_116333 crossref_primary_10_1097_HEP_0000000000000300 crossref_primary_10_1016_j_eprac_2022_03_014 crossref_primary_10_1016_j_eprac_2022_03_016 crossref_primary_10_1111_liv_15406 crossref_primary_10_1186_s12944_023_01855_7 crossref_primary_10_1097_CM9_0000000000003726 crossref_primary_10_3389_fendo_2025_1604991 crossref_primary_10_5306_wjco_v15_i11_1394 crossref_primary_10_1111_petr_14825 crossref_primary_10_1016_j_metabol_2024_156080 crossref_primary_10_1016_j_cgh_2022_05_046 crossref_primary_10_1155_2022_6588144 crossref_primary_10_1186_s12944_025_02518_5 crossref_primary_10_1080_00325481_2024_2436344 crossref_primary_10_1097_HEP_0000000000000872 crossref_primary_10_14309_ajg_0000000000002951 crossref_primary_10_1016_j_freeradbiomed_2022_12_093 crossref_primary_10_1111_liv_15730 crossref_primary_10_1016_j_cell_2024_10_001 crossref_primary_10_3390_livers2010003 crossref_primary_10_1038_s41575_025_01081_9 crossref_primary_10_1097_CM9_0000000000002753 crossref_primary_10_1002_jgh3_12996 crossref_primary_10_1039_D2FO03028D crossref_primary_10_1097_HEP_0000000000000507 crossref_primary_10_1186_s12951_022_01540_4 crossref_primary_10_1038_s41575_021_00538_x crossref_primary_10_1172_JCI166149 crossref_primary_10_1111_liv_15629 crossref_primary_10_3390_toxins15070411 crossref_primary_10_1186_s12876_025_03921_z crossref_primary_10_1016_j_clnesp_2024_11_032 crossref_primary_10_1016_j_jhep_2023_03_040 crossref_primary_10_1016_j_jceh_2022_12_005 crossref_primary_10_3390_ijms25094836 crossref_primary_10_2337_dc24_2075 crossref_primary_10_4103_sjg_sjg_247_25 crossref_primary_10_1111_apt_16720 crossref_primary_10_1080_07391102_2023_2231544 crossref_primary_10_1002_jcsm_13432 crossref_primary_10_1186_s13578_022_00910_7 crossref_primary_10_1016_j_biocel_2025_106751 crossref_primary_10_1038_s41392_022_01111_x crossref_primary_10_1186_s12944_022_01660_8 crossref_primary_10_3389_fnut_2024_1361567 crossref_primary_10_1053_j_gastro_2023_11_007 crossref_primary_10_3390_metabo13010101 crossref_primary_10_1080_13696998_2025_2550113 crossref_primary_10_1152_ajpendo_00014_2024 crossref_primary_10_4254_wjh_v17_i2_97741 crossref_primary_10_1186_s41043_025_00973_5 crossref_primary_10_1371_journal_pone_0307500 crossref_primary_10_1016_S2468_1253_25_00131_1 crossref_primary_10_3390_ijms241411606 crossref_primary_10_1186_s41043_024_00721_1 crossref_primary_10_1038_s41575_023_00796_x crossref_primary_10_1016_j_jhep_2024_10_031 crossref_primary_10_1038_s41598_025_00237_6 crossref_primary_10_1016_j_biopha_2024_116250 crossref_primary_10_1016_j_metabol_2022_155220 crossref_primary_10_3390_ijms241914918 crossref_primary_10_1111_liv_15209 crossref_primary_10_31146_1682_8658_ecg_230_10_49_61 crossref_primary_10_3390_cancers15123092 crossref_primary_10_1080_15548627_2022_2128019 crossref_primary_10_3390_metabo15090624 crossref_primary_10_1249_MSS_0000000000003388 crossref_primary_10_2337_dsi23_0012 crossref_primary_10_7759_cureus_46380 crossref_primary_10_1097_HC9_0000000000000678 crossref_primary_10_1038_s41598_025_17534_9 crossref_primary_10_1016_j_cmet_2022_01_001 crossref_primary_10_1016_j_jep_2023_116927 crossref_primary_10_1177_20406223241303649 crossref_primary_10_1038_s41598_025_09073_0 crossref_primary_10_1186_s12944_023_01954_5 crossref_primary_10_1016_j_pcd_2022_01_005 crossref_primary_10_1016_j_fbio_2025_107483 crossref_primary_10_1007_s11938_022_00382_1 crossref_primary_10_4103_sjg_sjg_122_24 crossref_primary_10_7759_cureus_25495 crossref_primary_10_1177_00469580241241272 crossref_primary_10_1016_j_bbadis_2025_167666 crossref_primary_10_1016_j_jep_2024_119005 crossref_primary_10_1111_liv_15547 crossref_primary_10_1007_s11684_022_0960_z crossref_primary_10_15252_emmm_202318367 crossref_primary_10_1007_s13105_023_00998_6 crossref_primary_10_3390_ijms26062709 crossref_primary_10_1111_liv_15792 crossref_primary_10_3390_nu14163262 crossref_primary_10_2147_DMSO_S421840 crossref_primary_10_1002_adhm_202303785 crossref_primary_10_1016_S2468_1253_22_00008_5 crossref_primary_10_3389_fnut_2024_1502671 crossref_primary_10_1016_j_jconrel_2025_02_008 crossref_primary_10_3390_ijms241512015 crossref_primary_10_1111_liv_15914 crossref_primary_10_1016_j_ceca_2024_102895 crossref_primary_10_1109_TUFFC_2025_3555180 crossref_primary_10_1097_HEP_0000000000001461 crossref_primary_10_1016_j_cgh_2023_04_018 crossref_primary_10_1097_CM9_0000000000002135 crossref_primary_10_1038_s41575_023_00759_2 crossref_primary_10_3390_ijms231710065 crossref_primary_10_1097_HC9_0000000000000234 crossref_primary_10_1590_1806_9282_20230188 crossref_primary_10_3389_fmed_2024_1383112 crossref_primary_10_1016_j_livres_2023_08_004 crossref_primary_10_1097_MD_0000000000038008 crossref_primary_10_3390_molecules28010272 crossref_primary_10_2337_dci22_0034 crossref_primary_10_1002_ijc_34308 crossref_primary_10_1038_s41572_025_00599_1 crossref_primary_10_1159_000533946 crossref_primary_10_1007_s10519_022_10131_w crossref_primary_10_3390_molecules30153066 crossref_primary_10_3390_biom13030560 crossref_primary_10_1002_jia2_26072 crossref_primary_10_3390_nu15020427 crossref_primary_10_3389_fphar_2024_1444561 crossref_primary_10_1016_j_puhe_2025_02_028 crossref_primary_10_3389_fpubh_2023_1152809 crossref_primary_10_1016_j_jceh_2024_101407 crossref_primary_10_1016_j_metabol_2024_155958 crossref_primary_10_1038_s41598_023_33964_9 crossref_primary_10_1093_eurjpc_zwae336 crossref_primary_10_1016_j_cmet_2023_08_002 crossref_primary_10_3390_ijerph20064928 crossref_primary_10_1016_S2468_1253_23_00159_0 crossref_primary_10_1038_s41401_025_01568_w crossref_primary_10_3389_fonc_2023_1174788 crossref_primary_10_1016_j_tem_2022_08_001 crossref_primary_10_59093_27112330_134 crossref_primary_10_1186_s12944_024_02108_x crossref_primary_10_1097_HEP_0000000000000004 crossref_primary_10_3389_fcimb_2025_1586212 crossref_primary_10_1016_j_ejphar_2024_177033 crossref_primary_10_1097_HEP_0000000000000361 crossref_primary_10_1038_s41598_024_64034_3 crossref_primary_10_3389_fmed_2024_1427138 crossref_primary_10_1016_j_jad_2024_08_189 crossref_primary_10_3389_fendo_2023_1267996 crossref_primary_10_3390_medicina61091527 crossref_primary_10_1016_j_chemosphere_2023_139598 crossref_primary_10_3390_ijms232315109 crossref_primary_10_1016_j_omtn_2024_102184 crossref_primary_10_1016_S1875_5364_24_60690_4 crossref_primary_10_3389_fnut_2022_971913 crossref_primary_10_1186_s12958_025_01391_2 crossref_primary_10_1097_HEP_0000000000000696 crossref_primary_10_7759_cureus_84803 crossref_primary_10_4254_wjh_v15_i5_641 crossref_primary_10_1097_HEP_0000000000000694 crossref_primary_10_1111_liv_15951 crossref_primary_10_3390_ijms26125717 crossref_primary_10_1186_s12944_024_02281_z crossref_primary_10_1093_nutrit_nuad054 crossref_primary_10_1155_2023_8836452 crossref_primary_10_3390_antiox11071263 crossref_primary_10_1016_S0140_6736_25_01042_6 crossref_primary_10_1016_j_redox_2025_103499 crossref_primary_10_1097_HC9_0000000000000036 crossref_primary_10_1016_j_healthplace_2024_103392 crossref_primary_10_1016_j_phymed_2023_155229 crossref_primary_10_1186_s12937_023_00897_y crossref_primary_10_1097_HEP_0000000000000343 crossref_primary_10_3390_life15030363 crossref_primary_10_1016_j_jhep_2022_07_021 crossref_primary_10_1016_j_heliyon_2022_e11119 crossref_primary_10_1186_s12933_023_01945_x crossref_primary_10_1016_j_ajg_2024_02_003 crossref_primary_10_4254_wjh_v17_i3_105635 crossref_primary_10_1016_j_cld_2023_01_019 crossref_primary_10_1038_s41575_024_00918_z crossref_primary_10_1007_s12602_024_10219_1 crossref_primary_10_1016_j_cld_2023_01_015 crossref_primary_10_1016_j_cld_2023_01_016 crossref_primary_10_1001_jamanetworkopen_2023_53965 crossref_primary_10_1097_HEP_0000000000000679 crossref_primary_10_3390_cancers14246234 crossref_primary_10_1111_liv_15815 crossref_primary_10_1002_jbt_23595 crossref_primary_10_1161_JAHA_123_032997 crossref_primary_10_1039_D4FO06329E crossref_primary_10_1016_j_ajcnut_2023_02_008 crossref_primary_10_1097_CP9_0000000000000106 crossref_primary_10_3389_fimmu_2025_1569915 crossref_primary_10_1016_j_cgh_2022_11_030 crossref_primary_10_2147_IJGM_S413545 crossref_primary_10_3390_jcm12196216 crossref_primary_10_1111_hepr_13825 crossref_primary_10_3390_nu16121800 crossref_primary_10_1007_s00203_023_03752_0 crossref_primary_10_1007_s15034_023_4488_3 crossref_primary_10_1016_j_jceh_2022_11_006 crossref_primary_10_3389_fnut_2024_1340453 crossref_primary_10_1016_j_identj_2025_03_029 crossref_primary_10_1016_j_prmcm_2023_100335 crossref_primary_10_1159_000531981 crossref_primary_10_1111_liv_15707 crossref_primary_10_1097_HC9_0000000000000251 crossref_primary_10_1097_MEG_0000000000002986 crossref_primary_10_1093_labmed_lmac039 crossref_primary_10_1097_RCT_0000000000001521 crossref_primary_10_1111_liv_15941 crossref_primary_10_1002_ijgo_16118 crossref_primary_10_1111_apt_18024 crossref_primary_10_1016_j_heliyon_2024_e34915 crossref_primary_10_1016_j_jnutbio_2022_109189 crossref_primary_10_3389_fpubh_2024_1437432 crossref_primary_10_3390_obesities2020017 crossref_primary_10_2147_NSS_S524675 crossref_primary_10_1055_s_0042_1757711 crossref_primary_10_1055_s_0042_1757712 crossref_primary_10_3390_nu17172759 crossref_primary_10_1080_17446651_2022_2110864 crossref_primary_10_1038_s41575_021_00565_8 crossref_primary_10_3390_antiox11050898 crossref_primary_10_1113_JP284742 crossref_primary_10_3390_molecules29071494 crossref_primary_10_1038_s41467_022_34671_1 crossref_primary_10_1017_S0029665122002257 crossref_primary_10_1016_j_addr_2023_115117 crossref_primary_10_3389_fendo_2023_1073498 crossref_primary_10_1038_s41598_024_72795_0 crossref_primary_10_1016_j_jhep_2024_08_024 crossref_primary_10_4162_nrp_2023_17_1_62 crossref_primary_10_1001_jamanetworkopen_2023_35511 crossref_primary_10_1007_s11427_024_2722_2 crossref_primary_10_1007_s11606_025_09659_4 crossref_primary_10_1186_s12916_025_03879_5 crossref_primary_10_1016_j_ajpath_2023_03_009 crossref_primary_10_1016_j_nut_2022_111910 crossref_primary_10_1097_HEP_0000000000001190 crossref_primary_10_1111_dom_15014 crossref_primary_10_1016_j_medcle_2022_07_018 crossref_primary_10_2147_DMSO_S472778 crossref_primary_10_1097_MD_0000000000044527 crossref_primary_10_1111_dom_15016 crossref_primary_10_3390_biomedicines10061315 crossref_primary_10_1038_s41430_024_01489_7 crossref_primary_10_1080_14728222_2022_2133699 crossref_primary_10_1097_MEG_0000000000002959 crossref_primary_10_3389_fgene_2022_1020899 crossref_primary_10_1016_j_aohep_2024_101757 crossref_primary_10_3390_biomedicines11102711 crossref_primary_10_3390_ijms26020564 crossref_primary_10_1016_j_biopha_2022_113076 crossref_primary_10_1016_j_nexres_2025_100846 crossref_primary_10_3390_nu14142921 crossref_primary_10_3390_ijms24032844 crossref_primary_10_2337_dci24_0094 crossref_primary_10_3389_fnut_2024_1421386 crossref_primary_10_1016_j_heliyon_2024_e25460 crossref_primary_10_1007_s00592_024_02287_0 crossref_primary_10_1016_j_jhep_2023_07_029 crossref_primary_10_1002_fsn3_4348 crossref_primary_10_1038_s41575_023_00754_7 crossref_primary_10_3390_nu15020271 crossref_primary_10_1016_j_diabet_2024_101534 crossref_primary_10_1111_apt_70020 crossref_primary_10_62347_ZWSR4476 crossref_primary_10_1007_s00535_023_02040_4 crossref_primary_10_1016_j_aohep_2024_101528 crossref_primary_10_3389_fendo_2022_798417 crossref_primary_10_3390_life14060729 crossref_primary_10_1007_s12020_023_03467_8 crossref_primary_10_1097_HEP_0000000000001058 crossref_primary_10_3390_cancers15164097 crossref_primary_10_1016_j_tem_2024_02_007 crossref_primary_10_1016_j_jceh_2022_01_008 crossref_primary_10_1055_a_2435_2091 crossref_primary_10_1111_jdi_13756 crossref_primary_10_1002_jcb_30252 crossref_primary_10_1080_15376516_2023_2301344 crossref_primary_10_1016_j_jlr_2024_100513 crossref_primary_10_1002_mco2_70130 crossref_primary_10_1038_s41586_022_05398_2 crossref_primary_10_1080_17474124_2024_2388790 crossref_primary_10_2217_nnm_2022_0261 crossref_primary_10_1039_D2FO02349K crossref_primary_10_1055_a_2224_1196 crossref_primary_10_1016_j_obmed_2023_100527 crossref_primary_10_1007_s10620_023_08031_y crossref_primary_10_1080_00325481_2024_2325332 crossref_primary_10_3390_nu15173733 crossref_primary_10_1007_s10068_023_01464_1 crossref_primary_10_2217_pme_2022_0100 crossref_primary_10_1111_liv_16091 crossref_primary_10_1016_j_jpha_2023_06_002 crossref_primary_10_3389_fnut_2025_1624440 crossref_primary_10_1016_S2468_1253_25_00226_2 crossref_primary_10_14309_ajg_0000000000003594 crossref_primary_10_3390_jcm13164929 crossref_primary_10_1016_j_bbrc_2025_152161 crossref_primary_10_1055_s_0042_1751081 crossref_primary_10_1093_ibd_izad175 crossref_primary_10_1007_s10620_023_08186_8 crossref_primary_10_3389_fphar_2025_1505117 crossref_primary_10_1016_j_diabres_2025_112334 crossref_primary_10_4103_sjg_sjg_431_24 crossref_primary_10_1080_26896583_2023_2293493 crossref_primary_10_1016_S2468_1253_23_00198_X crossref_primary_10_3390_ijms25115965 crossref_primary_10_1038_s43856_024_00649_x crossref_primary_10_1002_jcla_24225 crossref_primary_10_1111_jgh_16676 crossref_primary_10_1055_a_1862_9088 crossref_primary_10_3389_fphar_2023_1194026 crossref_primary_10_2147_NDT_S375532 crossref_primary_10_1097_HEP_0000000000000397 crossref_primary_10_1371_journal_pbio_3002728 crossref_primary_10_1016_j_intimp_2024_112821 crossref_primary_10_1016_j_lfs_2024_122948 crossref_primary_10_1016_j_jconrel_2024_06_061 crossref_primary_10_1210_clinem_dgac624 crossref_primary_10_3390_ijms26094077 crossref_primary_10_3390_nu15102361 crossref_primary_10_1016_j_ejphar_2022_175378 crossref_primary_10_3389_fcimb_2025_1565298 crossref_primary_10_1007_s12664_024_01636_9 crossref_primary_10_1146_annurev_physiol_042222_024535 crossref_primary_10_1016_j_cgh_2021_12_029 crossref_primary_10_1080_07853890_2023_2255825 crossref_primary_10_1038_s41598_024_81120_8 crossref_primary_10_1111_hiv_13540 crossref_primary_10_1089_jmf_2023_0118 crossref_primary_10_1016_S2468_1253_25_00019_6 crossref_primary_10_1055_s_0043_1778127 crossref_primary_10_1249_MSS_0000000000003719 crossref_primary_10_1016_j_bbadis_2023_166656 crossref_primary_10_1016_j_freeradbiomed_2022_07_018 crossref_primary_10_3389_fendo_2022_935390 crossref_primary_10_3390_ijms24043672 crossref_primary_10_1016_j_intimp_2025_114053 crossref_primary_10_1002_path_6242 crossref_primary_10_1016_j_clnesp_2025_01_041 crossref_primary_10_3390_diagnostics13142439 crossref_primary_10_1007_s10620_023_08043_8 crossref_primary_10_1007_s11655_025_3832_y crossref_primary_10_1186_s13293_023_00569_w crossref_primary_10_1016_S2468_1253_22_00375_2 crossref_primary_10_3390_biom12060824 crossref_primary_10_1002_hep_32741 crossref_primary_10_1016_j_jff_2023_105715 crossref_primary_10_3389_fmed_2025_1589245 crossref_primary_10_1016_j_cmet_2022_05_003 |
| Cites_doi | 10.1053/j.gastro.2020.12.003 10.1038/s41575-021-00477-7 10.1016/j.jhep.2021.06.034 10.1002/hep.31726 10.1101/2021.08.02.21261464 10.1136/flgastro-2020-101480 10.1186/s12955-016-0420-z 10.1053/j.gastro.2020.01.043 10.2337/dc20-S004 10.1016/S0140-6736(11)60815-5 10.1111/joim.12972 10.1111/j.1445-5994.2012.02848.x 10.1016/S2468-1253(18)30270-X 10.1038/s41591-020-0803-x 10.1093/tbm/ibx086 10.1136/bmjopen-2016-015659 10.1038/sj.ijo.0801938 10.1038/nrgastro.2017.109 10.1016/S0140-6736(14)61743-8 10.1177/2040622319880392 10.1007/s10620-013-2942-0 10.1111/liv.13643 10.1186/s12916-018-1103-x 10.1053/j.gastro.2018.12.036 10.3109/07853890.2010.518623 10.1016/j.jhep.2020.03.036 10.1111/liv.14355 10.1007/978-3-319-23018-4_5 10.1016/S2468-1253(19)30349-8 10.9778/cmajo.20200009 10.1136/gutjnl-2017-313884 10.1080/17474124.2020.1801413 10.1016/j.jhep.2018.05.036 10.1111/jgh.13856 10.1002/hep.31611 10.1111/liv.14198 10.1002/hep.30846 10.1002/hep.28431 10.1016/j.jhep.2020.03.039 10.1155/2020/9181368 10.1002/hep.20842 10.1146/annurev-publhealth-032315-021353 10.1016/j.jhep.2019.04.011 10.1038/ajg.2016.453 10.1053/j.gastro.2015.05.039 10.3748/wjg.v24.i30.3361 10.1053/j.gastro.2019.11.312 10.1002/hep.30842 10.1097/MPG.0b013e318290d138 10.3748/wjg.15.473 10.1016/j.jhep.2015.05.022 10.1016/j.jhep.2021.01.015 10.1186/s12887-017-0867-z 10.1016/S2468-1253(20)30213-2 10.1016/j.jhepr.2020.100099 10.1016/j.cgh.2019.10.023 10.1016/S2468-1253(20)30077-7 10.1053/j.gastro.2018.08.024 10.1016/j.jhep.2019.08.027 10.1111/dme.14387 10.1016/j.jpeds.2018.11.021 10.1136/flgastro-2013-100404 10.1002/hep.31420 10.1186/s12876-019-1039-4 10.1186/s12889-020-09249-5 10.1053/j.gastro.2020.01.051 10.1002/cld.1045 10.14309/ajg.0000000000000484 10.1002/hep.29367 10.1007/s40271-020-00485-w 10.1111/liv.13658 10.1053/j.gastro.2015.04.043 10.1111/liv.13391 10.1111/liv.14360 10.1136/gutjnl-2020-322976 10.1038/s41575-019-0169-z 10.1016/S0140-6736(20)30925-9 10.1038/nrgastro.2015.146 10.1016/j.jhepr.2019.10.008 10.3389/fmed.2014.00004 10.1016/S0140-6736(18)31992-5 10.2105/AJPH.2009.159491 10.1002/hep.30251 10.1093/gastro/gov047 10.1016/S0140-6736(13)60063-X 10.1136/bmjopen-2014-006998 10.1001/jamaoncol.2019.2996 10.1136/flgastro-2013-100403 10.1038/s41467-021-24673-w 10.1007/s11901-017-0378-2 10.1016/j.jhepr.2019.08.002 10.1016/j.jhep.2018.07.020 10.1186/1471-230X-14-166 10.1186/s41687-018-0052-7 10.1053/j.gastro.2018.04.034 10.1542/peds.2006-1212 10.3390/ijms17050774 10.1016/j.jval.2017.08.1448 10.1016/S0140-6736(12)61851-0 10.1038/nrgastro.2013.41 10.1097/MCG.0000000000000075 10.1016/j.cgh.2017.04.040 10.1097/XCE.0000000000000128 10.1002/hep.28785 10.1136/flgastro-2019-101177 10.1161/01.cir.0000437739.71477.ee 10.1053/j.gastro.2019.08.048 10.1016/j.jhep.2019.03.033 10.1016/j.jhep.2017.05.016 10.1111/jgh.13857 10.1111/liv.14825 10.1016/j.jhep.2016.08.023 10.1016/S2468-1253(20)30340-X 10.1007/s12072-020-10094-2 10.1016/j.jhep.2020.08.028 10.1016/j.cgh.2018.12.016 10.1016/j.jhepr.2020.100142 10.1080/09595230500102434 10.1002/hep.29466 10.1136/flgastro-2018-101155 10.1016/j.jhepr.2021.100234 10.1016/S0140-6736(17)31267-9 10.1530/EJE-20-0065 10.1016/j.jhep.2014.12.012 10.1016/j.jhep.2016.03.019 10.1136/gutjnl-2016-313622 10.1016/j.aohep.2020.09.006 10.1002/hep.26183 10.3350/cmh.2020.0067 10.15403/jgld-775 10.1016/j.jhep.2013.09.015 10.1002/hep.22868 10.1093/qjmed/hct198 10.1016/j.jhep.2019.05.033 10.1186/s12916-018-1149-9 10.2337/dc16-1066 |
| ContentType | Journal Article |
| Contributor | de Ledinghen, Victor Hebditch, Vanessa Esmat, Gamal Kim, Seung Up Hickman, Ingrid J El Kassas, Mohamed Ghazinyan, Hasmik Andrade, Raúl J Khatry, Maryam Salem Al Bedri, Shahinaz Castillo-Lopez, Gabriela Lee, Nancy Murillo, Omar Alfaro Fan, Jian-Gao Bakieva, Shokhista Lange, Naomi F Åberg, Fredrik Cryer, Donna Dillon, John Alvaro, Domenico Bruha, Radan Korenjak, Marko Alqahtani, Saleh A Liu, Chun-Jen Duseja, Ajay Hocking, Samantha L Ayesha, Motala Kalamitsis, George Dorairaj, Prabhakaran Jamal, Mohammad H Kao, Jia-Horng Awuku, Yaw Asante Kugelmas, Marcelo Elsanousi, Osama M Coppell, Kirsten J Carrieri, Patrizia Craxi, Antonio Colombo, Massimo Demaio, Alessandro Isakov, Vasily A Bugianesi, Elisabetta Byrne, Christopher D Idilman, Ramazan Goh, George Boon-Bee Chang, Yoosoo Farpour-Lambert, Nathalie Song, Myeong Jun Calleja, Jose Luis Naamani, Khalid Al Gerber, Lynn Basu, Rita Corey, Kathleen Kaplan, Lee Khader, Yousef Fuchs, Michael Alnaser, Faisal Kawaguchi, Takumi DelPrato, Stefano Baatarkhuu, Oidov Dassanayake, Anuradha Bourliere, Marc Burra, Pat |
| Contributor_xml | – sequence: 1 givenname: Fredrik surname: Åberg fullname: Åberg, Fredrik – sequence: 2 givenname: Leon surname: Adams fullname: Adams, Leon – sequence: 3 givenname: Maryam Salem Al surname: Khatry fullname: Khatry, Maryam Salem Al – sequence: 4 givenname: Khalid Al surname: Naamani fullname: Naamani, Khalid Al – sequence: 5 givenname: Omar Alfaro surname: Murillo fullname: Murillo, Omar Alfaro – sequence: 6 givenname: Alina M surname: Allen fullname: Allen, Alina M – sequence: 7 givenname: Faisal surname: Alnaser fullname: Alnaser, Faisal – sequence: 8 givenname: Saleh A surname: Alqahtani fullname: Alqahtani, Saleh A – sequence: 9 givenname: Khalid surname: Alswat fullname: Alswat, Khalid – sequence: 10 givenname: Domenico surname: Alvaro fullname: Alvaro, Domenico – sequence: 11 givenname: Raúl J surname: Andrade fullname: Andrade, Raúl J – sequence: 12 givenname: Marco surname: Arrese fullname: Arrese, Marco – sequence: 13 givenname: Yaw Asante surname: Awuku fullname: Awuku, Yaw Asante – sequence: 14 givenname: Motala surname: Ayesha fullname: Ayesha, Motala – sequence: 15 givenname: Oidov surname: Baatarkhuu fullname: Baatarkhuu, Oidov – sequence: 16 givenname: Shokhista surname: Bakieva fullname: Bakieva, Shokhista – sequence: 17 givenname: Rita surname: Basu fullname: Basu, Rita – sequence: 18 givenname: Ramon surname: Bataller fullname: Bataller, Ramon – sequence: 19 givenname: Shahinaz surname: Bedri fullname: Bedri, Shahinaz – sequence: 20 givenname: Emanuele surname: Bosi fullname: Bosi, Emanuele – sequence: 21 givenname: Marc surname: Bourliere fullname: Bourliere, Marc – sequence: 22 givenname: Radan surname: Bruha fullname: Bruha, Radan – sequence: 23 givenname: Elisabetta surname: Bugianesi fullname: Bugianesi, Elisabetta – sequence: 24 givenname: Patrizia surname: Burra fullname: Burra, Patrizia – sequence: 25 givenname: Maria surname: Buti fullname: Buti, Maria – sequence: 26 givenname: Christopher D surname: Byrne fullname: Byrne, Christopher D – sequence: 27 givenname: Jose Luis surname: Calleja fullname: Calleja, Jose Luis – sequence: 28 givenname: Patrizia surname: Carrieri fullname: Carrieri, Patrizia – sequence: 29 givenname: Flloyd surname: Carter fullname: Carter, Flloyd – sequence: 30 givenname: Marlen Ivon Castellanos surname: Fernandez fullname: Fernandez, Marlen Ivon Castellanos – sequence: 31 givenname: Gabriela surname: Castillo-Lopez fullname: Castillo-Lopez, Gabriela – sequence: 32 givenname: Graciela E surname: Castro-Narro fullname: Castro-Narro, Graciela E – sequence: 33 givenname: Henry Lik Yuen surname: Chan fullname: Chan, Henry Lik Yuen – sequence: 34 givenname: Wah-Kheong surname: Chan fullname: Chan, Wah-Kheong – sequence: 35 givenname: Yoosoo surname: Chang fullname: Chang, Yoosoo – sequence: 36 givenname: Massimo surname: Colombo fullname: Colombo, Massimo – sequence: 37 givenname: Kirsten J surname: Coppell fullname: Coppell, Kirsten J – sequence: 38 givenname: Kathleen surname: Corey fullname: Corey, Kathleen – sequence: 39 givenname: Antonio surname: Craxi fullname: Craxi, Antonio – sequence: 40 givenname: Donna surname: Cryer fullname: Cryer, Donna – sequence: 41 givenname: Anuradha surname: Dassanayake fullname: Dassanayake, Anuradha – sequence: 42 givenname: Antonieta de Ascenção Soares surname: Martins fullname: Martins, Antonieta de Ascenção Soares – sequence: 43 givenname: Victor surname: de Ledinghen fullname: de Ledinghen, Victor – sequence: 44 givenname: Stefano surname: DelPrato fullname: DelPrato, Stefano – sequence: 45 givenname: Alessandro surname: Demaio fullname: Demaio, Alessandro – sequence: 46 givenname: Hailemichael surname: Desalegn fullname: Desalegn, Hailemichael – sequence: 47 givenname: John surname: Dillon fullname: Dillon, John – sequence: 48 givenname: Ajay surname: Duseja fullname: Duseja, Ajay – sequence: 49 givenname: Prabhakaran surname: Dorairaj fullname: Dorairaj, Prabhakaran – sequence: 50 givenname: Mattias surname: Ekstedt fullname: Ekstedt, Mattias – sequence: 51 givenname: Mohamed surname: El Kassas fullname: El Kassas, Mohamed – sequence: 52 givenname: Osama M surname: Elsanousi fullname: Elsanousi, Osama M – sequence: 53 givenname: Gamal surname: Esmat fullname: Esmat, Gamal – sequence: 54 givenname: Jian-Gao surname: Fan fullname: Fan, Jian-Gao – sequence: 55 givenname: Nathalie surname: Farpour-Lambert fullname: Farpour-Lambert, Nathalie – sequence: 56 givenname: Robert surname: Flisiak fullname: Flisiak, Robert – sequence: 57 givenname: Yasser surname: Fouad fullname: Fouad, Yasser – sequence: 58 givenname: Michael surname: Fuchs fullname: Fuchs, Michael – sequence: 59 givenname: Rino A surname: Gani fullname: Gani, Rino A – sequence: 60 givenname: Lynn surname: Gerber fullname: Gerber, Lynn – sequence: 61 givenname: Hasmik surname: Ghazinyan fullname: Ghazinyan, Hasmik – sequence: 62 givenname: Liana surname: Gheorghe fullname: Gheorghe, Liana – sequence: 63 givenname: George Boon-Bee surname: Goh fullname: Goh, George Boon-Bee – sequence: 64 givenname: Henning surname: Grønbæk fullname: Grønbæk, Henning – sequence: 65 givenname: Aghayeva surname: Gulnara fullname: Gulnara, Aghayeva – sequence: 66 givenname: Saeed surname: Hamid fullname: Hamid, Saeed – sequence: 67 givenname: Vanessa surname: Hebditch fullname: Hebditch, Vanessa – sequence: 68 givenname: Ingrid J surname: Hickman fullname: Hickman, Ingrid J – sequence: 69 givenname: Samantha L surname: Hocking fullname: Hocking, Samantha L – sequence: 70 givenname: Bela surname: Hunyady fullname: Hunyady, Bela – sequence: 71 givenname: Ramazan surname: Idilman fullname: Idilman, Ramazan – sequence: 72 givenname: Vasily A surname: Isakov fullname: Isakov, Vasily A – sequence: 73 givenname: Mohammad H surname: Jamal fullname: Jamal, Mohammad H – sequence: 74 givenname: Peter surname: Jepsen fullname: Jepsen, Peter – sequence: 75 givenname: Natacha Jreige surname: Iskandar fullname: Iskandar, Natacha Jreige – sequence: 76 givenname: Myeong Jun surname: Song fullname: Song, Myeong Jun – sequence: 77 givenname: K C surname: Sudhamshu fullname: Sudhamshu, K C – sequence: 78 givenname: Satoru surname: Kakizaki fullname: Kakizaki, Satoru – sequence: 79 givenname: George surname: Kalamitsis fullname: Kalamitsis, George – sequence: 80 givenname: Fasiha surname: Kanwal fullname: Kanwal, Fasiha – sequence: 81 givenname: Jia-Horng surname: Kao fullname: Kao, Jia-Horng – sequence: 82 givenname: Lee surname: Kaplan fullname: Kaplan, Lee – sequence: 83 givenname: Takumi surname: Kawaguchi fullname: Kawaguchi, Takumi – sequence: 84 givenname: Yousef surname: Khader fullname: Khader, Yousef – sequence: 85 givenname: Seung Up surname: Kim fullname: Kim, Seung Up – sequence: 86 givenname: Nicolas surname: Kodjoh fullname: Kodjoh, Nicolas – sequence: 87 givenname: Ger surname: Koek fullname: Koek, Ger – sequence: 88 givenname: Kazuhiko surname: Koike fullname: Koike, Kazuhiko – sequence: 89 givenname: Narcisse Patrice surname: Komas fullname: Komas, Narcisse Patrice – sequence: 90 givenname: Marko surname: Korenjak fullname: Korenjak, Marko – sequence: 91 givenname: Marcelo surname: Kugelmas fullname: Kugelmas, Marcelo – sequence: 92 givenname: Asma surname: Labidi fullname: Labidi, Asma – sequence: 93 givenname: Naomi F surname: Lange fullname: Lange, Naomi F – sequence: 94 givenname: Joel E surname: Lavine fullname: Lavine, Joel E – sequence: 95 givenname: Mariana surname: Lazo fullname: Lazo, Mariana – sequence: 96 givenname: Nancy surname: Lee fullname: Lee, Nancy – sequence: 97 givenname: Cosmas Rinaldi A surname: Lesmana fullname: Lesmana, Cosmas Rinaldi A – sequence: 98 givenname: Chun-Jen surname: Liu fullname: Liu, Chun-Jen – sequence: 99 givenname: Michelle T surname: Long fullname: Long, Michelle T – sequence: 100 givenname: Patricio surname: Lopez-Jaramillo fullname: Lopez-Jaramillo, Patricio |
| Copyright | Springer Nature Limited 2021. corrected publication 2021 2021. Springer Nature Limited. Springer Nature Limited 2021. corrected publication 2021. |
| Copyright_xml | – notice: Springer Nature Limited 2021. corrected publication 2021 – notice: 2021. Springer Nature Limited. – notice: Springer Nature Limited 2021. corrected publication 2021. |
| CorporateAuthor | the NAFLD Consensus Consortium NAFLD Consensus Consortium |
| CorporateAuthor_xml | – name: the NAFLD Consensus Consortium – name: NAFLD Consensus Consortium |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 ADTPV AOWAS D8T ZZAVC |
| DOI | 10.1038/s41575-021-00523-4 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Central Student MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1759-5053 |
| EndPage | 78 |
| ExternalDocumentID | oai_swepub_ki_se_458004 34707258 10_1038_s41575_021_00523_4 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Review |
| GroupedDBID | --- 0R~ 29M 39C 3V. 53G 70F 7X7 88E 8FE 8FH 8FI 8FJ AAEEF AAQQT AARCD AASDW AAWTL AAWYQ AAYZH AAZLF ABAWZ ABJNI ABLJU ABUWG ACGFS ADBBV AENEX AFKRA AFSHS AGAYW AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB AXYYD BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU DB5 EBS EE. EJD EXGXG F5P FQGFK FSGXE FYUFA HCIFZ HMCUK HZ~ IAO IHR IHW INH INR ITC LK8 M1P M7P NNMJJ ODYON OVD PQQKQ PROAC PSQYO RNR RNT RNTTT SHXYY SIXXV SNYQT SOJ TAOOD TBHMF TDRGL TEORI TSG UKHRP AAYXX ABFSG ACSTC AEZWR AFANA AFHIU AGSTI AHWEU AIXLP ALPWD ATHPR CITATION CGR CUY CVF ECM EIF NFIDA NPM PHGZM PHGZT PJZUB PPXIY PQGLB 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI 7X8 PUEGO ADTPV AFFHD AOWAS D8T ZZAVC |
| ID | FETCH-LOGICAL-c549t-3c0de189e18aa8aa87b574ebe3f94a5e00cbaa85307231e16b929534d6ff6ac03 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 565 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000712475600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1759-5045 1759-5053 |
| IngestDate | Tue Nov 25 03:20:59 EST 2025 Thu Oct 02 13:59:48 EDT 2025 Tue Oct 07 06:48:56 EDT 2025 Mon Jul 21 04:15:35 EDT 2025 Tue Nov 18 22:01:32 EST 2025 Sat Nov 29 01:32:48 EST 2025 Fri Feb 21 02:37:05 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2021. Springer Nature Limited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c549t-3c0de189e18aa8aa87b574ebe3f94a5e00cbaa85307231e16b929534d6ff6ac03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-9518-0088 0000-0002-6715-8588 0000-0001-5544-5187 0000-0001-8494-8947 0000-0002-4832-9564 0000-0002-7527-4714 0000-0002-0544-5610 0000-0002-4845-9991 0000-0002-8537-8744 0000-0002-8421-5476 0000-0003-2215-9410 0000-0002-8561-396X 0000-0001-8248-0172 0000-0002-4224-4703 0000-0001-9618-2299 0000-0001-6371-3997 0000-0003-4518-5283 0000-0002-8022-4279 0000-0001-8592-5878 |
| OpenAccessLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:148057598 |
| PMID | 34707258 |
| PQID | 2613007461 |
| PQPubID | 2042741 |
| PageCount | 19 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_458004 proquest_miscellaneous_2587738204 proquest_journals_2613007461 pubmed_primary_34707258 crossref_primary_10_1038_s41575_021_00523_4 crossref_citationtrail_10_1038_s41575_021_00523_4 springer_journals_10_1038_s41575_021_00523_4 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-01-01 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Nature reviews. Gastroenterology & hepatology |
| PublicationTitleAbbrev | Nat Rev Gastroenterol Hepatol |
| PublicationTitleAlternate | Nat Rev Gastroenterol Hepatol |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Ye (CR35) 2020; 5 Berentzen, Gamborg, Holst, Sørensen, Baker (CR52) 2014; 60 Eslam (CR115) 2020; 14 Haldar (CR13) 2019; 71 Bergqvist (CR65) 2013; 43 Yüksel (CR44) 2012; 16 Nobili (CR48) 2019; 16 Hashida (CR123) 2017; 66 CR157 Chalmers (CR83) 2020; 11 Younossi (CR6) 2016; 64 Musso, Gambino, Cassader, Pagano (CR37) 2011; 43 Castera (CR100) 2018; 38 Hagström, Stål, Hultcrantz, Hemmingsson, Andreasson (CR53) 2016; 65 Nadeau (CR50) 2016; 39 Bennett (CR26) 2018; 392 Zimmermann (CR51) 2015; 5 Castera, Friedrich-Rust, Loomba (CR95) 2019; 156 Romero-Gómez, Zelber-Sagi, Trenell (CR118) 2017; 67 Srivastava (CR89) 2019; 19 Anstee (CR98) 2019; 70 Taylor (CR94) 2020; 158 Vos (CR30) 2020; 396 Park, Seo, Shin, Ryoo (CR24) 2013; 57 Albhaisi, Chowdhury, Sanyal (CR19) 2019; 1 Gordon, Fraysse, Li, Ozbay, Wong (CR8) 2020; 115 Wieland (CR67) 2015; 49 Terrault, Pageaux (CR14) 2018; 69 Mosca, Panera, Crudele, Alisi (CR103) 2020; 14 Ratziu (CR153) 2020; 73 Peters (CR105) 2019; 10 Majumdar, Campos, Gurusamy, Pinzani, Tsochatzis (CR101) 2020; 71 Srivastava (CR87) 2019; 71 Shaheen (CR86) 2020; 8 David (CR60) 2009; 49 Huang (CR143) 2015; 385 Alemany-Pagès (CR66) 2020; 20 Dixon, Embi, Haggstrom (CR108) 2018; 8 Spearman (CR151) 2021; 74 Himmelstein, Puhl (CR132) 2021; 38 Puhl, Heuer (CR129) 2010; 100 Anstee, Targher, Day (CR17) 2013; 10 Younossi (CR20) 2018; 15 Angulo (CR22) 2015; 149 Targher, Byrne (CR147) 2020; 6 Vaughn-Sandler, Sherman, Aronsohn, Volk (CR131) 2014; 59 DeVore (CR79) 2013; 57 Vali (CR96) 2020; 73 CR135 Xanthakos (CR41) 2015; 149 de Franchis (CR71) 2015; 63 CR136 Byrne, Targher (CR18) 2015; 62 Younossi (CR56) 2017; 37 Leoni (CR110) 2018; 24 Yu (CR42) 2019; 207 Lazarus (CR73) 2021 Schwimmer (CR43) 2006; 118 Dyson, Anstee, McPherson (CR75) 2014; 5 Younossi (CR34) 2019; 69 Grgurevic (CR74) 2020; 2020 Younossi (CR154) 2021; 73 Golabi (CR1) 2016; 14 Sanyal (CR64) 2018; 16 CR146 Vilar-Gomez (CR21) 2018; 155 Hagström (CR7) 2020; 18 Alexander (CR91) 2018; 16 Lazarus (CR134) 2021; 75 CR145 CR142 Simon (CR55) 2021 Armstrong (CR78) 2014; 107 Tanajewski (CR90) 2017; 7 Anderson (CR39) 2015; 10 Dillon (CR84) 2019; 71 McPherson (CR97) 2017; 112 Schattenberg (CR4) 2021; 41 Doward (CR57) 2021; 14 Huang, Drewnosksi, Kumanyika, Glass (CR141) 2009; 6 Chitturi (CR114) 2018; 33 Hagström (CR63) 2021 Wong (CR155) 2018; 33 Estes, Razavi, Loomba, Younossi, Sanyal (CR33) 2018; 67 Lazarus (CR124) 2020; 72 Jimenez-Rivera (CR40) 2017; 17 Jung (CR102) 2021; 70 (CR111) 2016; 64 Hagström, Tynelius, Rasmussen (CR54) 2018; 67 (CR156) 2020; 43 CR70 Bjorkstrom, Stal, Hultcrantz, Hagstrom (CR36) 2017; 15 Rocha (CR45) 2009; 15 Kumanyika, Jeffery, Morabia, Ritenbaugh, Antipatis (CR139) 2002; 26 O’Hara (CR3) 2020; 2 Eslam, Sanyal, George (CR149) 2020; 158 Ando, Jou (CR109) 2021; 17 Casey, Schwartz, Stewart, Adler (CR62) 2016; 37 Gortmaker (CR140) 2011; 378 Eslam (CR148) 2020; 73 Muthiah, Sanyal (CR116) 2020; 40 Goh (CR68) 2016; 4 Kennedy-Martin, Bae, Paczkowski, Freeman (CR61) 2017; 2 Rutter (CR138) 2017; 390 Berná, Romero-Gomez (CR122) 2020; 40 Mencin, Loomba, Lavine (CR93) 2015; 12 Fuchs, Henschke, Blümel, Busse (CR106) 2014; 111 Twiss (CR58) 2017; 20 Jensen (CR119) 2014; 129 Younossi (CR31) 2016; 64 Schwimmer (CR47) 2005; 42 Neilson (CR81) 2021 CR85 Kanwal (CR12) 2018; 155 Estes (CR32) 2018; 69 Crossan (CR88) 2019; 39 Ahmed, Woodward, Mital (CR77) 2017; 6 Hydes, Ravi, Loomba, Gray (CR120) 2020; 26 CR128 Dyson, Anstee, McPherson (CR82) 2014; 5 Lazarus (CR72) 2019; 286 Wong (CR126) 2015; 10 (CR15) 2019; 5 Bertot, Adams (CR9) 2016; 17 Lazarus (CR133) 2021; 3 Lazarus (CR144) 2021 Di Cesare (CR104) 2013; 381 Adams, Anstee, Tilg, Targher (CR16) 2017; 66 Neuschwander-Tetri (CR125) 2020; 158 Shiha (CR152) 2021; 6 Younossi (CR5) 2020 Room (CR130) 2005; 24 Cooke (CR92) 2019; 4 Ruissen, Mak, Beuers, Tushuizen, Holleboom (CR76) 2020; 183 Arab (CR112) 2020; 19 Vos (CR49) 2019; 157 Hallsworth, Adams (CR117) 2019; 1 Araújo, Rosso, Bedogni, Tiribelli, Bellentani (CR11) 2018; 38 Mendez-Sanchez (CR150) 2021; 6 Martin, Williams, Haskard, Dimatteo (CR127) 2005; 1 CR27 CR25 Geurtsen, Santos, Gaillard, Felix, Jaddoe (CR121) 2021; 73 Chalasani (CR113) 2018; 67 Atun (CR137) 2013; 381 McSweeney (CR2) 2020; 2 Zhang (CR46) 2021; 11 Rubino (CR28) 2020; 26 Ekstedt, Nasr, Kechagias (CR10) 2017; 16 Augustin (CR99) 2020; 29 Huber (CR59) 2019; 17 Lazarus (CR29) 2021; 12 Ghevariya (CR69) 2014; 1 Haflidadottir (CR23) 2014; 14 Sepanlou (CR38) 2020; 5 Moolla (CR80) 2019; 10 CR107 J Chalmers (523_CR83) 2020; 11 N Mendez-Sanchez (523_CR150) 2021; 6 A Moolla (523_CR80) 2019; 10 523_CR70 AR Araújo (523_CR11) 2018; 38 EL Yu (523_CR42) 2019; 207 R de Franchis (523_CR71) 2015; 63 JV Lazarus (523_CR134) 2021; 75 E Zimmermann (523_CR51) 2015; 5 JB Schwimmer (523_CR43) 2006; 118 H Hagström (523_CR53) 2016; 65 S DeVore (523_CR79) 2013; 57 523_CR107 BE Dixon (523_CR108) 2018; 8 JV Lazarus (523_CR144) 2021 R Peters (523_CR105) 2019; 10 BA Neuschwander-Tetri (523_CR125) 2020; 158 MD Jensen (523_CR119) 2014; 129 S Leoni (523_CR110) 2018; 24 AJ Sanyal (523_CR64) 2018; 16 European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (523_CR111) 2016; 64 SC Gordon (523_CR8) 2020; 115 LC Doward (523_CR57) 2021; 14 S Albhaisi (523_CR19) 2019; 1 LA Adams (523_CR16) 2017; 66 L Tanajewski (523_CR90) 2017; 7 TJ Hydes (523_CR120) 2020; 26 P Angulo (523_CR22) 2015; 149 ELY Wong (523_CR126) 2015; 10 H Hagström (523_CR63) 2021 TT Huang (523_CR141) 2009; 6 JV Lazarus (523_CR124) 2020; 72 A Srivastava (523_CR89) 2019; 19 Global Burden of Disease Cancer Collaboration (523_CR15) 2019; 5 S Haflidadottir (523_CR23) 2014; 14 M Eslam (523_CR149) 2020; 158 C Estes (523_CR33) 2018; 67 V Vaughn-Sandler (523_CR131) 2014; 59 ZM Younossi (523_CR5) 2020 H Hagström (523_CR54) 2018; 67 M Di Cesare (523_CR104) 2013; 381 V Ghevariya (523_CR69) 2014; 1 R Hashida (523_CR123) 2017; 66 CD Byrne (523_CR18) 2015; 62 QM Anstee (523_CR98) 2019; 70 ZM Younossi (523_CR56) 2017; 37 VW Wong (523_CR155) 2018; 33 L McSweeney (523_CR2) 2020; 2 Q Ye (523_CR35) 2020; 5 Y Ando (523_CR109) 2021; 17 MS Himmelstein (523_CR132) 2021; 38 JV Lazarus (523_CR73) 2021 P Golabi (523_CR1) 2016; 14 AA Mencin (523_CR93) 2015; 12 JB Schwimmer (523_CR47) 2005; 42 Y Huber (523_CR59) 2019; 17 H Hagström (523_CR7) 2020; 18 JE Bennett (523_CR26) 2018; 392 JK Dyson (523_CR82) 2014; 5 NA Terrault (523_CR14) 2018; 69 M Romero-Gómez (523_CR118) 2017; 67 G Berná (523_CR122) 2020; 40 S Chitturi (523_CR114) 2018; 33 JF Dillon (523_CR84) 2019; 71 E Vilar-Gomez (523_CR21) 2018; 155 TG Simon (523_CR55) 2021 JA Casey (523_CR62) 2016; 37 F Yüksel (523_CR44) 2012; 16 K David (523_CR60) 2009; 49 V Nobili (523_CR48) 2019; 16 Y Vali (523_CR96) 2020; 73 JV Lazarus (523_CR72) 2019; 286 LJ Neilson (523_CR81) 2021 523_CR157 LR Martin (523_CR127) 2005; 1 G Shiha (523_CR152) 2021; 6 V Ratziu (523_CR153) 2020; 73 G Musso (523_CR37) 2011; 43 SA Xanthakos (523_CR41) 2015; 149 T Vos (523_CR30) 2020; 396 523_CR142 TT Huang (523_CR143) 2015; 385 JP Arab (523_CR112) 2020; 19 ML Geurtsen (523_CR121) 2021; 73 JM Schattenberg (523_CR4) 2021; 41 I Grgurevic (523_CR74) 2020; 2020 LC Bertot (523_CR9) 2016; 17 523_CR27 523_CR25 523_CR145 523_CR146 QM Anstee (523_CR17) 2013; 10 TL Berentzen (523_CR52) 2014; 60 SL Gortmaker (523_CR140) 2011; 378 ZM Younossi (523_CR6) 2016; 64 C Crossan (523_CR88) 2019; 39 A Mosca (523_CR103) 2020; 14 F Rubino (523_CR28) 2020; 26 MM Ruissen (523_CR76) 2020; 183 K Bjorkstrom (523_CR36) 2017; 15 JV Lazarus (523_CR133) 2021; 3 R Rocha (523_CR45) 2009; 15 D Haldar (523_CR13) 2019; 71 MJ Armstrong (523_CR78) 2014; 107 A Srivastava (523_CR87) 2019; 71 MD Muthiah (523_CR116) 2020; 40 S Kumanyika (523_CR139) 2002; 26 EL Anderson (523_CR39) 2015; 10 X Zhang (523_CR46) 2021; 11 523_CR136 American Diabetes Association. (523_CR156) 2020; 43 GBB Goh (523_CR68) 2016; 4 S Augustin (523_CR99) 2020; 29 523_CR135 KJ Nadeau (523_CR50) 2016; 39 J O’Hara (523_CR3) 2020; 2 M Ekstedt (523_CR10) 2017; 16 AA Shaheen (523_CR86) 2020; 8 L Castera (523_CR95) 2019; 156 Z Younossi (523_CR34) 2019; 69 CW Spearman (523_CR151) 2021; 74 RS Taylor (523_CR94) 2020; 158 GS Cooke (523_CR92) 2019; 4 A Majumdar (523_CR101) 2020; 71 S Fuchs (523_CR106) 2014; 111 JV Lazarus (523_CR29) 2021; 12 C Estes (523_CR32) 2018; 69 H Rutter (523_CR138) 2017; 390 523_CR85 L Castera (523_CR100) 2018; 38 MB Vos (523_CR49) 2019; 157 CJ Bergqvist (523_CR65) 2013; 43 N Chalasani (523_CR113) 2018; 67 M Eslam (523_CR115) 2020; 14 MH Ahmed (523_CR77) 2017; 6 M Alexander (523_CR91) 2018; 16 523_CR128 G Targher (523_CR147) 2020; 6 ZM Younossi (523_CR31) 2016; 64 J Jung (523_CR102) 2021; 70 C Jimenez-Rivera (523_CR40) 2017; 17 RM Puhl (523_CR129) 2010; 100 F Kanwal (523_CR12) 2018; 155 SK Park (523_CR24) 2013; 57 R Room (523_CR130) 2005; 24 R Atun (523_CR137) 2013; 381 M Eslam (523_CR148) 2020; 73 SG Sepanlou (523_CR38) 2020; 5 M Alemany-Pagès (523_CR66) 2020; 20 K Hallsworth (523_CR117) 2019; 1 T Kennedy-Martin (523_CR61) 2017; 2 S McPherson (523_CR97) 2017; 112 Z Younossi (523_CR20) 2018; 15 J Twiss (523_CR58) 2017; 20 AC Wieland (523_CR67) 2015; 49 JK Dyson (523_CR75) 2014; 5 ZM Younossi (523_CR154) 2021; 73 |
| References_xml | – volume: 66 start-page: 142 year: 2017 end-page: 152 ident: CR123 article-title: Aerobic vs resistance exercise in non-alcoholic fatty liver disease: a systematic review publication-title: J. Hepatol. – volume: 129 start-page: S102 year: 2014 end-page: S138 ident: CR119 article-title: 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society publication-title: Circulation – volume: 156 start-page: 1264 year: 2019 end-page: 1281.e4 ident: CR95 article-title: Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 6 start-page: 64 year: 2020 ident: CR147 article-title: From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: is it time for a change of terminology? publication-title: Hepatoma Res. – volume: 57 start-page: 1378 year: 2013 end-page: 1383 ident: CR24 article-title: Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study publication-title: Hepatology – volume: 63 start-page: 743 year: 2015 end-page: 752 ident: CR71 article-title: Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying Risk and Individualizing Care for Portal Hypertension publication-title: J. Hepatol. – volume: 73 start-page: 1194 year: 2021 end-page: 1198 ident: CR154 article-title: From NAFLD to MAFLD: implications of a premature change in terminology publication-title: Hepatology – volume: 112 start-page: 740 year: 2017 end-page: 751 ident: CR97 article-title: Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis publication-title: Am. J. Gastroenterol. – ident: CR135 – volume: 74 start-page: 1256 year: 2021 end-page: 1258 ident: CR151 article-title: The sub-Saharan Africa position statement on the redefinition of fatty liver disease: from NAFLD to MAFLD publication-title: J. Hepatol. – volume: 71 start-page: 627 year: 2020 end-page: 642 ident: CR101 article-title: Defining the minimum acceptable diagnostic accuracy of noninvasive fibrosis testing in cirrhosis: a decision analytic modeling study publication-title: Hepatology – volume: 6 start-page: 109 year: 2017 end-page: 112 ident: CR77 article-title: Metabolic clinic for individuals with HIV/AIDS: a commitment and vision to the future of HIV services publication-title: Cardiovasc. Endocrinol. – volume: 10 year: 2015 ident: CR39 article-title: The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis publication-title: PLoS ONE – volume: 111 start-page: 453 year: 2014 end-page: 463 ident: CR106 article-title: Disease management programs for type 2 diabetes in Germany: a systematic literature review evaluating effectiveness publication-title: Dtsch. Arztebl Int. – volume: 5 start-page: 739 year: 2020 end-page: 752 ident: CR35 article-title: Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Lancet Gastroenterol. Hepatol. – volume: 385 start-page: 2422 year: 2015 end-page: 2431 ident: CR143 article-title: Mobilisation of public support for policy actions to prevent obesity publication-title: Lancet – volume: 43 start-page: 247 year: 2013 end-page: 253 ident: CR65 article-title: Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists publication-title: Intern. Med. J. – volume: 19 start-page: 122 year: 2019 ident: CR89 article-title: Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease publication-title: BMC Gastroenterol. – ident: CR25 – volume: 6 start-page: 57 year: 2021 end-page: 64 ident: CR152 article-title: Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa publication-title: Lancet Gastroenterol. Hepatol. – volume: 71 start-page: 371 year: 2019 end-page: 378 ident: CR87 article-title: Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease publication-title: J. Hepatol. – volume: 69 start-page: 2672 year: 2019 end-page: 2682 ident: CR34 article-title: Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis publication-title: Hepatology – volume: 37 start-page: 1209 year: 2017 end-page: 1218 ident: CR56 article-title: A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD publication-title: Liver Int. – volume: 26 start-page: 485 year: 2020 end-page: 497 ident: CR28 article-title: Joint international consensus statement for ending stigma of obesity publication-title: Nat. Med. – volume: 49 start-page: 1904 year: 2009 end-page: 1912 ident: CR60 article-title: Quality of life in adults with nonalcoholic fatty liver disease: baseline data from the Nonalcoholic Ateatohepatitis Clinical Research Network publication-title: Hepatology – volume: 38 start-page: 67 issue: Suppl 1 year: 2018 end-page: 70 ident: CR100 article-title: Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: non-invasive tests are enough publication-title: Liver Int. – volume: 38 year: 2021 ident: CR132 article-title: At multiple fronts: diabetes stigma and weight stigma in adults with type 2 diabetes publication-title: Diabet. Med. – volume: 60 start-page: 325 year: 2014 end-page: 330 ident: CR52 article-title: Body mass index in childhood and adult risk of primary liver cancer publication-title: J. Hepatol. – volume: 67 start-page: 328 year: 2018 end-page: 357 ident: CR113 article-title: The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases publication-title: Hepatology – volume: 10 year: 2015 ident: CR126 article-title: Patient experience and satisfaction with inpatient service: development of short form survey instrument measuring the core aspect of inpatient experience publication-title: PLoS ONE – volume: 37 start-page: 61 year: 2016 end-page: 81 ident: CR62 article-title: Using electronic health records for population health research: a review of methods and applications publication-title: Annu. Rev. Public Health – volume: 396 start-page: 1204 year: 2020 end-page: 1222 ident: CR30 article-title: Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet – ident: CR85 – volume: 17 start-page: 2085 year: 2019 end-page: 2092.e1 ident: CR59 article-title: Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation publication-title: Clin. Gastroenterol. Hepatol. – volume: 390 start-page: 2602 year: 2017 end-page: 2604 ident: CR138 article-title: The need for a complex systems model of evidence for public health publication-title: Lancet – volume: 70 start-page: 1946 year: 2021 end-page: 1953 ident: CR102 article-title: MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis publication-title: Gut – volume: 118 start-page: 1388 year: 2006 end-page: 1393 ident: CR43 article-title: Prevalence of fatty liver in children and adolescents publication-title: Pediatrics – volume: 59 start-page: 681 year: 2014 end-page: 686 ident: CR131 article-title: Consequences of perceived stigma among patients with cirrhosis publication-title: Dig. Dis. Sci. – volume: 115 start-page: 562 year: 2020 end-page: 574 ident: CR8 article-title: Disease severity is associated with higher healthcare utilization in nonalcoholic steatohepatitis Medicare patients publication-title: Am. J. Gastroenterol. – volume: 1 start-page: 329 year: 2019 end-page: 341 ident: CR19 article-title: Non-alcoholic fatty liver disease in lean individuals publication-title: JHEP Rep.: Innov. Hepatol. – volume: 16 start-page: 391 year: 2017 end-page: 397 ident: CR10 article-title: Natural history of NAFLD/NASH publication-title: Curr. Hepatol. Rep. – volume: 17 start-page: 113 year: 2017 ident: CR40 article-title: Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity publication-title: BMC Pediatr. – volume: 16 start-page: 61 year: 2012 end-page: 65 ident: CR44 article-title: Fatty liver disease in an autopsy series of children and adolescents publication-title: Hippokratia – volume: 155 start-page: 443 year: 2018 end-page: 457.e17 ident: CR21 article-title: Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study publication-title: Gastroenterology – volume: 11 start-page: 86 year: 2020 end-page: 92 ident: CR83 article-title: The development and implementation of a commissioned pathway for the identification and stratification of liver disease in the community publication-title: Front. Gastroenterol. – volume: 1 start-page: 468 year: 2019 end-page: 479 ident: CR117 article-title: Lifestyle modification in NAFLD/NASH: facts and figures publication-title: JHEP Rep. Innov. Hepatol. – volume: 62 start-page: S47 year: 2015 end-page: S64 ident: CR18 article-title: NAFLD: a multisystem disease publication-title: J. Hepatol. – volume: 16 year: 2018 ident: CR91 article-title: Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease publication-title: BMC Med. – volume: 29 start-page: 235 year: 2020 end-page: 245 ident: CR99 article-title: Identification of patients with advanced fibrosis due to nonalcoholic fatty liver disease: considerations for best practice publication-title: J. Gastrointestin Liver Dis. – volume: 26 start-page: 425 year: 2002 end-page: 436 ident: CR139 article-title: Obesity prevention: the case for action publication-title: Int. J. Obes. Relat. Metab. Disord. – volume: 16 start-page: 517 year: 2019 end-page: 530 ident: CR48 article-title: NAFLD in children: new genes, new diagnostic modalities and new drugs publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 12 start-page: 617 year: 2015 end-page: 628 ident: CR93 article-title: Caring for children with NAFLD and navigating their care into adulthood publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 1 start-page: 189 year: 2005 end-page: 199 ident: CR127 article-title: The challenge of patient adherence publication-title: Ther. Clin. Risk Manag. – volume: 100 start-page: 1019 year: 2010 end-page: 1028 ident: CR129 article-title: Obesity stigma: important considerations for public health publication-title: Am. J. Public Health – volume: 5 start-page: 211 year: 2014 end-page: 218 ident: CR82 article-title: Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging publication-title: Front. Gastroenterol. – volume: 39 start-page: 1635 year: 2016 end-page: 1642 ident: CR50 article-title: Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities publication-title: Diabetes Care – ident: CR27 – volume: 14 start-page: 18 year: 2016 ident: CR1 article-title: Non-alcoholic fatty liver disease (NAFLD) is associated with impairment of health related quality of life (HRQOL) publication-title: Health Qual. Life Outcomes – year: 2020 ident: CR5 article-title: The association of histologic and noninvasive tests with adverse clinical and patient-reported outcomes in patients with advanced fibrosis due to nonalcoholic steatohepatitis publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.12.003 – ident: CR142 – volume: 43 start-page: S37 year: 2020 end-page: S47 ident: CR156 article-title: Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes — 2020 publication-title: Diabetes Care – volume: 155 start-page: 1828 year: 2018 end-page: 1837.e2 ident: CR12 article-title: Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease publication-title: Gastroenterology – volume: 158 start-page: 1984 year: 2020 end-page: 1998.e3 ident: CR125 article-title: Therapeutic landscape for NAFLD in 2020 publication-title: Gastroenterology – volume: 392 start-page: 1072 year: 2018 end-page: 1088 ident: CR26 article-title: NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 publication-title: Lancet – year: 2021 ident: CR73 article-title: Defining comprehensive models of care for NAFLD publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00477-7 – volume: 381 start-page: 585 year: 2013 end-page: 597 ident: CR104 article-title: Inequalities in non-communicable diseases and effective responses publication-title: Lancet – volume: 14 start-page: 1035 year: 2020 end-page: 1046 ident: CR103 article-title: Noninvasive diagnostic tools for pediatric NAFLD: where are we now? publication-title: Expert Rev. Gastroenterol. Hepatol. – volume: 16 year: 2018 ident: CR64 article-title: Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing? publication-title: BMC Med. – volume: 11 year: 2021 ident: CR46 article-title: Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study publication-title: BMJ Open – volume: 286 start-page: 503 year: 2019 end-page: 525 ident: CR72 article-title: We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade publication-title: J. Intern. Med. – volume: 10 start-page: 2040622319880392 year: 2019 end-page: 2040622319880392 ident: CR105 article-title: Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction publication-title: Ther. Adv. Chronic Dis. – ident: CR128 – ident: CR145 – volume: 42 start-page: 641 year: 2005 end-page: 649 ident: CR47 article-title: Histopathology of pediatric nonalcoholic fatty liver disease publication-title: Hepatology – volume: 7 year: 2017 ident: CR90 article-title: Economic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study publication-title: BMJ Open – ident: CR70 – volume: 15 start-page: 11 year: 2018 end-page: 20 ident: CR20 article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 381 start-page: 690 year: 2013 end-page: 697 ident: CR137 article-title: Improving responsiveness of health systems to non-communicable diseases publication-title: Lancet – volume: 15 start-page: 473 year: 2009 end-page: 477 ident: CR45 article-title: Nonalcoholic fatty liver disease in asymptomatic Brazilian adolescents publication-title: World J. Gastroenterol. – volume: 158 start-page: 1999 year: 2020 end-page: 2014.e1 ident: CR149 article-title: MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease publication-title: Gastroenterology – volume: 67 start-page: 123 year: 2018 end-page: 133 ident: CR33 article-title: Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease publication-title: Hepatology – volume: 2 start-page: 100099 year: 2020 ident: CR2 article-title: Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis publication-title: JHEP Rep. – volume: 41 start-page: 1227 year: 2021 end-page: 1242 ident: CR4 article-title: Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in five European countries in 2018: a cost-of-illness analysis publication-title: Liver Int. – volume: 183 start-page: R57 year: 2020 end-page: R73 ident: CR76 article-title: Non-alcoholic fatty liver disease: a multidisciplinary approach towards a cardiometabolic liver disease publication-title: Eur. J. Endocrinol. – volume: 8 start-page: 522 year: 2018 end-page: 525 ident: CR108 article-title: Information technologies that facilitate care coordination: provider and patient perspectives publication-title: Transl. Behav. Med. – volume: 10 start-page: 330 year: 2013 end-page: 344 ident: CR17 article-title: Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis publication-title: Nat. Rev. Gastroenterol. Hepatol. – volume: 67 start-page: 1536 year: 2018 end-page: 1542 ident: CR54 article-title: High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men publication-title: Gut – volume: 40 start-page: 89 issue: Suppl. 1 year: 2020 end-page: 95 ident: CR116 article-title: Current management of non-alcoholic steatohepatitis publication-title: Liver Int. – volume: 14 start-page: 166 year: 2014 ident: CR23 article-title: Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease publication-title: BMC Gastroenterol. – volume: 157 start-page: 1448 year: 2019 end-page: 1456.e1 ident: CR49 article-title: Factors to consider in development of drugs for pediatric nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 149 start-page: 623 year: 2015 end-page: 634.e8 ident: CR41 article-title: High prevalence of nonalcoholic fatty liver disease in adolescents undergoing bariatric surgery publication-title: Gastroenterology – volume: 3 start-page: 100234 year: 2021 ident: CR133 article-title: European ‘NAFLD Preparedness Index’–is Europe ready to meet the challenge of fatty liver disease? publication-title: JHEP Rep. – volume: 18 start-page: 1592 year: 2020 end-page: 1599.e8 ident: CR7 article-title: Health care costs of patients with biopsy-confirmed nonalcoholic fatty liver disease are nearly twice those of matched controls publication-title: Clin. Gastroenterol. Hepatol. – volume: 69 start-page: 767 year: 2018 end-page: 768 ident: CR14 article-title: A changing landscape of liver transplantation: king HCV is dethroned, ALD and NAFLD take over! publication-title: J. Hepatol. – volume: 2020 start-page: 9181368 year: 2020 ident: CR74 article-title: Natural history of nonalcoholic fatty liver disease: implications for clinical practice and an individualized approach publication-title: Can. J. Gastroenterol. Hepatol. – volume: 17 start-page: 23 year: 2021 end-page: 28 ident: CR109 article-title: Nonalcoholic fatty liver disease and recent guideline updates publication-title: Clin. Liver Dis. – volume: 73 start-page: 560 year: 2021 end-page: 570 ident: CR121 article-title: Associations between intake of sugar-containing beverages in infancy with liver fat accumulation at school age publication-title: Hepatology – volume: 65 start-page: 363 year: 2016 end-page: 368 ident: CR53 article-title: Overweight in late adolescence predicts development of severe liver disease later in life: a 39years follow-up study publication-title: J. Hepatol. – ident: CR157 – volume: 15 start-page: 1461 year: 2017 end-page: 1468 ident: CR36 article-title: Histologic scores for fat and fibrosis associate with development of type 2 diabetes in patients with nonalcoholic fatty liver disease publication-title: Clin. Gastroenterol. Hepatol. – volume: 71 start-page: 699 year: 2019 end-page: 706 ident: CR84 article-title: Intelligent liver function testing (iLFT): a trial of automated diagnosis and staging of liver disease in primary care publication-title: J. Hepatol. – volume: 207 start-page: 64 year: 2019 end-page: 70 ident: CR42 article-title: Prevalence of nonalcoholic fatty liver disease in children with obesity publication-title: J. Pediatr. – ident: CR136 – volume: 1 start-page: 4 year: 2014 ident: CR69 article-title: Knowing what’s out there: awareness of non-alcoholic fatty liver disease publication-title: Front. Med. – volume: 19 start-page: 674 year: 2020 end-page: 690 ident: CR112 article-title: Latin American Association for the Study of the Liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease publication-title: Ann. Hepatol. – volume: 378 start-page: 838 year: 2011 end-page: 847 ident: CR140 article-title: Changing the future of obesity: science, policy, and action publication-title: Lancet – volume: 20 start-page: 1142 year: 2020 end-page: 1142 ident: CR66 article-title: Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance? publication-title: BMC Public Health – volume: 73 start-page: 252 year: 2020 end-page: 262 ident: CR96 article-title: Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: a systematic review and meta-analysis publication-title: J. Hepatol. – volume: 43 start-page: 617 year: 2011 end-page: 649 ident: CR37 article-title: Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity publication-title: Ann. Med. – volume: 5 start-page: 1749 year: 2019 end-page: 1768 ident: CR15 article-title: Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study publication-title: JAMA Oncol. – volume: 64 start-page: 1577 year: 2016 end-page: 1586 ident: CR6 article-title: The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe publication-title: Hepatology – volume: 71 start-page: 313 year: 2019 end-page: 322 ident: CR13 article-title: Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European Liver Transplant Registry study publication-title: J. Hepatol. – year: 2021 ident: CR55 article-title: Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.06.034 – volume: 2 start-page: 28 year: 2017 ident: CR61 article-title: Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review publication-title: J. Patient Rep. Outcomes – volume: 57 start-page: 119 year: 2013 end-page: 123 ident: CR79 article-title: A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD publication-title: J. Pediatr. Gastroenterol. Nutr. – volume: 39 start-page: 2052 year: 2019 end-page: 2060 ident: CR88 article-title: Referral pathways for patients with NAFLD based on non-invasive fibrosis tests: diagnostic accuracy and cost analysis publication-title: Liver Int. – volume: 14 start-page: 889 year: 2020 end-page: 919 ident: CR115 article-title: The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease publication-title: Hepatol. Int. – volume: 158 start-page: 1611 year: 2020 end-page: 1625.e12 ident: CR94 article-title: Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis publication-title: Gastroenterology – volume: 4 start-page: 131 year: 2016 end-page: 135 ident: CR68 article-title: Perceptions of non-alcoholic fatty liver disease – an Asian community-based study publication-title: Gastroenterol. Rep. – volume: 64 start-page: 1388 year: 2016 end-page: 1402 ident: CR111 article-title: EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease publication-title: J. Hepatol. – volume: 17 start-page: 774 year: 2016 ident: CR9 article-title: The natural course of non-alcoholic fatty liver disease publication-title: Int. J. Mol. Sci. – volume: 6 start-page: 65 year: 2021 end-page: 72 ident: CR150 article-title: The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease publication-title: Lancet Gastroenterol. Hepatol. – volume: 38 start-page: 47 year: 2018 end-page: 51 ident: CR11 article-title: Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: what we need in the future publication-title: Liver Int. – volume: 149 start-page: 389 year: 2015 end-page: 397.e10 ident: CR22 article-title: Liver fibrosis, but no other histologic features, is asssociated with long-term outcomes of patients with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 5 start-page: 245 year: 2020 end-page: 266 ident: CR38 article-title: The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet Gastroenterol. Hepatol. – volume: 5 start-page: 277 year: 2014 end-page: 286 ident: CR75 article-title: Non-alcoholic fatty liver disease: a practical approach to treatment publication-title: Frontline Gastroenterol. – volume: 33 start-page: 86 year: 2018 end-page: 98 ident: CR114 article-title: The Asia–Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017–Part 2: Management and special groups publication-title: J. Gastroenterol. Hepatol. – volume: 64 start-page: 73 year: 2016 end-page: 84 ident: CR31 article-title: Global epidemiology of nonalcoholic fatty liver disease–meta-analytic assessment of prevalence, incidence, and outcomes publication-title: Hepatology – volume: 14 start-page: 533 year: 2021 end-page: 543 ident: CR57 article-title: Development of a patient-reported outcome measure for non-alcoholic steatohepatitis (NASH-CHECK): results of a qualitative study publication-title: Patient – volume: 70 start-page: 1521 year: 2019 end-page: 1530 ident: CR98 article-title: Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials publication-title: Hepatology – volume: 26 start-page: 383 year: 2020 end-page: 400 ident: CR120 article-title: Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH publication-title: Clin. Mol. Hepatol. – volume: 33 start-page: 70 year: 2018 end-page: 85 ident: CR155 article-title: Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017–Part 1: definition, risk factors and assessment publication-title: J. Gastroenterol. Hepatol. – ident: CR146 – year: 2021 ident: CR63 article-title: Administrative coding in electronic health care record-based research of NAFLD: an expert panel consensus statement publication-title: Hepatology doi: 10.1002/hep.31726 – volume: 20 start-page: A638 year: 2017 ident: CR58 article-title: Development of a new patient-reported outcome measure for non-alcoholic steatohepatitis: NASH-CHECK [abstract PGI39] publication-title: Value Health – volume: 107 start-page: 33 year: 2014 end-page: 41 ident: CR78 article-title: Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management publication-title: QJM – volume: 24 start-page: 3361 year: 2018 end-page: 3373 ident: CR110 article-title: Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis publication-title: World J. Gastroenterol. – volume: 66 start-page: 1138 year: 2017 end-page: 1153 ident: CR16 article-title: Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases publication-title: Gut – volume: 75 start-page: 23 issue: Suppl. 2 year: 2021 end-page: 26 ident: CR134 article-title: The global non-alcoholic fatty liver disease (NAFLD) preparedness index: are countries ready to tackle the challenge? publication-title: Int. Liver Congr. – volume: 2 start-page: 100142 year: 2020 ident: CR3 article-title: Cost of non-alcoholic steatohepatitis in Europe and the USA: the GAIN study publication-title: JHEP Rep. – volume: 69 start-page: 896 year: 2018 end-page: 904 ident: CR32 article-title: Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 publication-title: J. Hepatol. – volume: 5 year: 2015 ident: CR51 article-title: Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register publication-title: BMJ Open – volume: 8 start-page: E370 year: 2020 end-page: E376 ident: CR86 article-title: Risk stratification of patients with nonalcoholic fatty liver disease using a case identification pathway in primary care: a cross-sectional study publication-title: CMAJ Open – year: 2021 ident: CR144 article-title: A Sustainable Development Goal framework to guide multisectoral action on NAFLD through a societal approach. Preprint at publication-title: medRxiv doi: 10.1101/2021.08.02.21261464 – volume: 67 start-page: 829 year: 2017 end-page: 846 ident: CR118 article-title: Treatment of NAFLD with diet, physical activity and exercise publication-title: J. Hepatol. – volume: 24 start-page: 143 year: 2005 end-page: 155 ident: CR130 article-title: Stigma, social inequality and alcohol and drug use publication-title: Drug Alcohol. Rev. – volume: 10 start-page: 337 year: 2019 end-page: 346 ident: CR80 article-title: A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health publication-title: Frontline Gastroenterol. – volume: 73 start-page: 1307 year: 2020 end-page: 1309 ident: CR153 article-title: The times they are a-changin’ (for NAFLD as well) publication-title: J. Hepatol. – year: 2021 ident: CR81 article-title: Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease publication-title: Frontline Gastroenterol. doi: 10.1136/flgastro-2020-101480 – volume: 40 start-page: 102 issue: Suppl. 1 year: 2020 end-page: 108 ident: CR122 article-title: The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management publication-title: Liver Int. – volume: 12 year: 2021 ident: CR29 article-title: Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV publication-title: Nat. Commun. – volume: 49 start-page: e6 year: 2015 end-page: e10 ident: CR67 article-title: Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk publication-title: J. Clin. Gastroenterol. – volume: 4 start-page: 135 year: 2019 end-page: 184 ident: CR92 article-title: Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission publication-title: Lancet Gastroenterol. Hepatol. – ident: CR107 – volume: 72 start-page: 14 year: 2020 end-page: 24 ident: CR124 article-title: A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe publication-title: J. Hepatol. – volume: 73 start-page: 202 year: 2020 end-page: 209 ident: CR148 article-title: A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement publication-title: J. Hepatol. – volume: 6 start-page: A82 year: 2009 ident: CR141 article-title: A systems-oriented multilevel framework for addressing obesity in the 21st century publication-title: Prev. Chronic Dis. – year: 2021 ident: 523_CR55 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.06.034 – ident: 523_CR146 – volume: 14 start-page: 18 year: 2016 ident: 523_CR1 publication-title: Health Qual. Life Outcomes doi: 10.1186/s12955-016-0420-z – ident: 523_CR27 – volume: 158 start-page: 1611 year: 2020 ident: 523_CR94 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.01.043 – volume: 43 start-page: S37 year: 2020 ident: 523_CR156 publication-title: Diabetes Care doi: 10.2337/dc20-S004 – volume: 378 start-page: 838 year: 2011 ident: 523_CR140 publication-title: Lancet doi: 10.1016/S0140-6736(11)60815-5 – volume: 286 start-page: 503 year: 2019 ident: 523_CR72 publication-title: J. Intern. Med. doi: 10.1111/joim.12972 – volume: 10 year: 2015 ident: 523_CR39 publication-title: PLoS ONE – volume: 43 start-page: 247 year: 2013 ident: 523_CR65 publication-title: Intern. Med. J. doi: 10.1111/j.1445-5994.2012.02848.x – volume: 4 start-page: 135 year: 2019 ident: 523_CR92 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(18)30270-X – volume: 26 start-page: 485 year: 2020 ident: 523_CR28 publication-title: Nat. Med. doi: 10.1038/s41591-020-0803-x – volume: 8 start-page: 522 year: 2018 ident: 523_CR108 publication-title: Transl. Behav. Med. doi: 10.1093/tbm/ibx086 – volume: 7 year: 2017 ident: 523_CR90 publication-title: BMJ Open doi: 10.1136/bmjopen-2016-015659 – volume: 26 start-page: 425 year: 2002 ident: 523_CR139 publication-title: Int. J. Obes. Relat. Metab. Disord. doi: 10.1038/sj.ijo.0801938 – volume: 15 start-page: 11 year: 2018 ident: 523_CR20 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2017.109 – volume: 385 start-page: 2422 year: 2015 ident: 523_CR143 publication-title: Lancet doi: 10.1016/S0140-6736(14)61743-8 – volume: 10 start-page: 204062231988039 year: 2019 ident: 523_CR105 publication-title: Ther. Adv. Chronic Dis. doi: 10.1177/2040622319880392 – volume: 59 start-page: 681 year: 2014 ident: 523_CR131 publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-013-2942-0 – volume: 38 start-page: 47 year: 2018 ident: 523_CR11 publication-title: Liver Int. doi: 10.1111/liv.13643 – volume: 16 year: 2018 ident: 523_CR91 publication-title: BMC Med. doi: 10.1186/s12916-018-1103-x – volume: 156 start-page: 1264 year: 2019 ident: 523_CR95 publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.12.036 – volume: 43 start-page: 617 year: 2011 ident: 523_CR37 publication-title: Ann. Med. doi: 10.3109/07853890.2010.518623 – volume: 73 start-page: 252 year: 2020 ident: 523_CR96 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.03.036 – volume: 40 start-page: 89 issue: Suppl. 1 year: 2020 ident: 523_CR116 publication-title: Liver Int. doi: 10.1111/liv.14355 – ident: 523_CR70 doi: 10.1007/978-3-319-23018-4_5 – year: 2020 ident: 523_CR5 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.12.003 – volume: 5 start-page: 245 year: 2020 ident: 523_CR38 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(19)30349-8 – volume: 16 start-page: 61 year: 2012 ident: 523_CR44 publication-title: Hippokratia – volume: 8 start-page: E370 year: 2020 ident: 523_CR86 publication-title: CMAJ Open doi: 10.9778/cmajo.20200009 – volume: 66 start-page: 1138 year: 2017 ident: 523_CR16 publication-title: Gut doi: 10.1136/gutjnl-2017-313884 – volume: 14 start-page: 1035 year: 2020 ident: 523_CR103 publication-title: Expert Rev. Gastroenterol. Hepatol. doi: 10.1080/17474124.2020.1801413 – volume: 69 start-page: 896 year: 2018 ident: 523_CR32 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.05.036 – volume: 33 start-page: 86 year: 2018 ident: 523_CR114 publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/jgh.13856 – volume: 73 start-page: 560 year: 2021 ident: 523_CR121 publication-title: Hepatology doi: 10.1002/hep.31611 – volume: 39 start-page: 2052 year: 2019 ident: 523_CR88 publication-title: Liver Int. doi: 10.1111/liv.14198 – volume: 71 start-page: 627 year: 2020 ident: 523_CR101 publication-title: Hepatology doi: 10.1002/hep.30846 – volume: 64 start-page: 73 year: 2016 ident: 523_CR31 publication-title: Hepatology doi: 10.1002/hep.28431 – volume: 73 start-page: 202 year: 2020 ident: 523_CR148 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.03.039 – volume: 2020 start-page: 9181368 year: 2020 ident: 523_CR74 publication-title: Can. J. Gastroenterol. Hepatol. doi: 10.1155/2020/9181368 – volume: 42 start-page: 641 year: 2005 ident: 523_CR47 publication-title: Hepatology doi: 10.1002/hep.20842 – ident: 523_CR25 – volume: 37 start-page: 61 year: 2016 ident: 523_CR62 publication-title: Annu. Rev. Public Health doi: 10.1146/annurev-publhealth-032315-021353 – volume: 71 start-page: 313 year: 2019 ident: 523_CR13 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.04.011 – volume: 112 start-page: 740 year: 2017 ident: 523_CR97 publication-title: Am. J. Gastroenterol. doi: 10.1038/ajg.2016.453 – volume: 149 start-page: 623 year: 2015 ident: 523_CR41 publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.05.039 – volume: 24 start-page: 3361 year: 2018 ident: 523_CR110 publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v24.i30.3361 – volume: 158 start-page: 1999 year: 2020 ident: 523_CR149 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.11.312 – volume: 70 start-page: 1521 year: 2019 ident: 523_CR98 publication-title: Hepatology doi: 10.1002/hep.30842 – volume: 10 year: 2015 ident: 523_CR126 publication-title: PLoS ONE – volume: 57 start-page: 119 year: 2013 ident: 523_CR79 publication-title: J. Pediatr. Gastroenterol. Nutr. doi: 10.1097/MPG.0b013e318290d138 – volume: 15 start-page: 473 year: 2009 ident: 523_CR45 publication-title: World J. Gastroenterol. doi: 10.3748/wjg.15.473 – volume: 63 start-page: 743 year: 2015 ident: 523_CR71 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2015.05.022 – ident: 523_CR157 – year: 2021 ident: 523_CR81 publication-title: Frontline Gastroenterol. doi: 10.1136/flgastro-2020-101480 – year: 2021 ident: 523_CR73 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-021-00477-7 – volume: 74 start-page: 1256 year: 2021 ident: 523_CR151 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2021.01.015 – volume: 17 start-page: 113 year: 2017 ident: 523_CR40 publication-title: BMC Pediatr. doi: 10.1186/s12887-017-0867-z – volume: 6 start-page: 57 year: 2021 ident: 523_CR152 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(20)30213-2 – volume: 2 start-page: 100099 year: 2020 ident: 523_CR2 publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2020.100099 – volume: 18 start-page: 1592 year: 2020 ident: 523_CR7 publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2019.10.023 – volume: 5 start-page: 739 year: 2020 ident: 523_CR35 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(20)30077-7 – ident: 523_CR135 – volume: 75 start-page: 23 issue: Suppl. 2 year: 2021 ident: 523_CR134 publication-title: Int. Liver Congr. – volume: 155 start-page: 1828 year: 2018 ident: 523_CR12 publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.08.024 – volume: 72 start-page: 14 year: 2020 ident: 523_CR124 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.08.027 – volume: 38 year: 2021 ident: 523_CR132 publication-title: Diabet. Med. doi: 10.1111/dme.14387 – volume: 207 start-page: 64 year: 2019 ident: 523_CR42 publication-title: J. Pediatr. doi: 10.1016/j.jpeds.2018.11.021 – volume: 5 start-page: 277 year: 2014 ident: 523_CR75 publication-title: Frontline Gastroenterol. doi: 10.1136/flgastro-2013-100404 – volume: 64 start-page: 1388 year: 2016 ident: 523_CR111 publication-title: J. Hepatol. – volume: 73 start-page: 1194 year: 2021 ident: 523_CR154 publication-title: Hepatology doi: 10.1002/hep.31420 – volume: 6 start-page: 64 year: 2020 ident: 523_CR147 publication-title: Hepatoma Res. – volume: 19 start-page: 122 year: 2019 ident: 523_CR89 publication-title: BMC Gastroenterol. doi: 10.1186/s12876-019-1039-4 – volume: 20 start-page: 1142 year: 2020 ident: 523_CR66 publication-title: BMC Public Health doi: 10.1186/s12889-020-09249-5 – volume: 158 start-page: 1984 year: 2020 ident: 523_CR125 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.01.051 – volume: 17 start-page: 23 year: 2021 ident: 523_CR109 publication-title: Clin. Liver Dis. doi: 10.1002/cld.1045 – volume: 115 start-page: 562 year: 2020 ident: 523_CR8 publication-title: Am. J. Gastroenterol. doi: 10.14309/ajg.0000000000000484 – volume: 67 start-page: 328 year: 2018 ident: 523_CR113 publication-title: Hepatology doi: 10.1002/hep.29367 – volume: 14 start-page: 533 year: 2021 ident: 523_CR57 publication-title: Patient doi: 10.1007/s40271-020-00485-w – volume: 38 start-page: 67 issue: Suppl 1 year: 2018 ident: 523_CR100 publication-title: Liver Int. doi: 10.1111/liv.13658 – volume: 149 start-page: 389 year: 2015 ident: 523_CR22 publication-title: Gastroenterology doi: 10.1053/j.gastro.2015.04.043 – volume: 37 start-page: 1209 year: 2017 ident: 523_CR56 publication-title: Liver Int. doi: 10.1111/liv.13391 – volume: 40 start-page: 102 issue: Suppl. 1 year: 2020 ident: 523_CR122 publication-title: Liver Int. doi: 10.1111/liv.14360 – volume: 70 start-page: 1946 year: 2021 ident: 523_CR102 publication-title: Gut doi: 10.1136/gutjnl-2020-322976 – ident: 523_CR142 – volume: 16 start-page: 517 year: 2019 ident: 523_CR48 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/s41575-019-0169-z – volume: 396 start-page: 1204 year: 2020 ident: 523_CR30 publication-title: Lancet doi: 10.1016/S0140-6736(20)30925-9 – volume: 12 start-page: 617 year: 2015 ident: 523_CR93 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2015.146 – volume: 1 start-page: 468 year: 2019 ident: 523_CR117 publication-title: JHEP Rep. Innov. Hepatol. doi: 10.1016/j.jhepr.2019.10.008 – ident: 523_CR136 – volume: 1 start-page: 4 year: 2014 ident: 523_CR69 publication-title: Front. Med. doi: 10.3389/fmed.2014.00004 – volume: 392 start-page: 1072 year: 2018 ident: 523_CR26 publication-title: Lancet doi: 10.1016/S0140-6736(18)31992-5 – ident: 523_CR107 – volume: 100 start-page: 1019 year: 2010 ident: 523_CR129 publication-title: Am. J. Public Health doi: 10.2105/AJPH.2009.159491 – volume: 69 start-page: 2672 year: 2019 ident: 523_CR34 publication-title: Hepatology doi: 10.1002/hep.30251 – volume: 4 start-page: 131 year: 2016 ident: 523_CR68 publication-title: Gastroenterol. Rep. doi: 10.1093/gastro/gov047 – volume: 381 start-page: 690 year: 2013 ident: 523_CR137 publication-title: Lancet doi: 10.1016/S0140-6736(13)60063-X – volume: 5 year: 2015 ident: 523_CR51 publication-title: BMJ Open doi: 10.1136/bmjopen-2014-006998 – volume: 5 start-page: 1749 year: 2019 ident: 523_CR15 publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2019.2996 – volume: 5 start-page: 211 year: 2014 ident: 523_CR82 publication-title: Front. Gastroenterol. doi: 10.1136/flgastro-2013-100403 – volume: 12 year: 2021 ident: 523_CR29 publication-title: Nat. Commun. doi: 10.1038/s41467-021-24673-w – volume: 16 start-page: 391 year: 2017 ident: 523_CR10 publication-title: Curr. Hepatol. Rep. doi: 10.1007/s11901-017-0378-2 – volume: 1 start-page: 329 year: 2019 ident: 523_CR19 publication-title: JHEP Rep.: Innov. Hepatol. doi: 10.1016/j.jhepr.2019.08.002 – volume: 69 start-page: 767 year: 2018 ident: 523_CR14 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2018.07.020 – year: 2021 ident: 523_CR144 publication-title: medRxiv doi: 10.1101/2021.08.02.21261464 – volume: 14 start-page: 166 year: 2014 ident: 523_CR23 publication-title: BMC Gastroenterol. doi: 10.1186/1471-230X-14-166 – volume: 2 start-page: 28 year: 2017 ident: 523_CR61 publication-title: J. Patient Rep. Outcomes doi: 10.1186/s41687-018-0052-7 – volume: 155 start-page: 443 year: 2018 ident: 523_CR21 publication-title: Gastroenterology doi: 10.1053/j.gastro.2018.04.034 – volume: 118 start-page: 1388 year: 2006 ident: 523_CR43 publication-title: Pediatrics doi: 10.1542/peds.2006-1212 – volume: 17 start-page: 774 year: 2016 ident: 523_CR9 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms17050774 – volume: 20 start-page: A638 year: 2017 ident: 523_CR58 publication-title: Value Health doi: 10.1016/j.jval.2017.08.1448 – year: 2021 ident: 523_CR63 publication-title: Hepatology doi: 10.1002/hep.31726 – volume: 381 start-page: 585 year: 2013 ident: 523_CR104 publication-title: Lancet doi: 10.1016/S0140-6736(12)61851-0 – volume: 10 start-page: 330 year: 2013 ident: 523_CR17 publication-title: Nat. Rev. Gastroenterol. Hepatol. doi: 10.1038/nrgastro.2013.41 – volume: 49 start-page: e6 year: 2015 ident: 523_CR67 publication-title: J. Clin. Gastroenterol. doi: 10.1097/MCG.0000000000000075 – volume: 15 start-page: 1461 year: 2017 ident: 523_CR36 publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2017.04.040 – volume: 6 start-page: 109 year: 2017 ident: 523_CR77 publication-title: Cardiovasc. Endocrinol. doi: 10.1097/XCE.0000000000000128 – volume: 64 start-page: 1577 year: 2016 ident: 523_CR6 publication-title: Hepatology doi: 10.1002/hep.28785 – volume: 11 start-page: 86 year: 2020 ident: 523_CR83 publication-title: Front. Gastroenterol. doi: 10.1136/flgastro-2019-101177 – volume: 129 start-page: S102 year: 2014 ident: 523_CR119 publication-title: Circulation doi: 10.1161/01.cir.0000437739.71477.ee – volume: 157 start-page: 1448 year: 2019 ident: 523_CR49 publication-title: Gastroenterology doi: 10.1053/j.gastro.2019.08.048 – volume: 71 start-page: 371 year: 2019 ident: 523_CR87 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.03.033 – volume: 67 start-page: 829 year: 2017 ident: 523_CR118 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2017.05.016 – volume: 33 start-page: 70 year: 2018 ident: 523_CR155 publication-title: J. Gastroenterol. Hepatol. doi: 10.1111/jgh.13857 – volume: 41 start-page: 1227 year: 2021 ident: 523_CR4 publication-title: Liver Int. doi: 10.1111/liv.14825 – volume: 111 start-page: 453 year: 2014 ident: 523_CR106 publication-title: Dtsch. Arztebl Int. – volume: 66 start-page: 142 year: 2017 ident: 523_CR123 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.08.023 – volume: 6 start-page: 65 year: 2021 ident: 523_CR150 publication-title: Lancet Gastroenterol. Hepatol. doi: 10.1016/S2468-1253(20)30340-X – volume: 11 year: 2021 ident: 523_CR46 publication-title: BMJ Open – volume: 14 start-page: 889 year: 2020 ident: 523_CR115 publication-title: Hepatol. Int. doi: 10.1007/s12072-020-10094-2 – ident: 523_CR128 – volume: 73 start-page: 1307 year: 2020 ident: 523_CR153 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2020.08.028 – volume: 17 start-page: 2085 year: 2019 ident: 523_CR59 publication-title: Clin. Gastroenterol. Hepatol. doi: 10.1016/j.cgh.2018.12.016 – volume: 2 start-page: 100142 year: 2020 ident: 523_CR3 publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2020.100142 – volume: 24 start-page: 143 year: 2005 ident: 523_CR130 publication-title: Drug Alcohol. Rev. doi: 10.1080/09595230500102434 – volume: 67 start-page: 123 year: 2018 ident: 523_CR33 publication-title: Hepatology doi: 10.1002/hep.29466 – volume: 10 start-page: 337 year: 2019 ident: 523_CR80 publication-title: Frontline Gastroenterol. doi: 10.1136/flgastro-2018-101155 – volume: 3 start-page: 100234 year: 2021 ident: 523_CR133 publication-title: JHEP Rep. doi: 10.1016/j.jhepr.2021.100234 – ident: 523_CR145 – volume: 390 start-page: 2602 year: 2017 ident: 523_CR138 publication-title: Lancet doi: 10.1016/S0140-6736(17)31267-9 – volume: 183 start-page: R57 year: 2020 ident: 523_CR76 publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-20-0065 – volume: 62 start-page: S47 year: 2015 ident: 523_CR18 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2014.12.012 – volume: 65 start-page: 363 year: 2016 ident: 523_CR53 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2016.03.019 – volume: 67 start-page: 1536 year: 2018 ident: 523_CR54 publication-title: Gut doi: 10.1136/gutjnl-2016-313622 – volume: 19 start-page: 674 year: 2020 ident: 523_CR112 publication-title: Ann. Hepatol. doi: 10.1016/j.aohep.2020.09.006 – volume: 1 start-page: 189 year: 2005 ident: 523_CR127 publication-title: Ther. Clin. Risk Manag. – volume: 57 start-page: 1378 year: 2013 ident: 523_CR24 publication-title: Hepatology doi: 10.1002/hep.26183 – volume: 26 start-page: 383 year: 2020 ident: 523_CR120 publication-title: Clin. Mol. Hepatol. doi: 10.3350/cmh.2020.0067 – ident: 523_CR85 – volume: 29 start-page: 235 year: 2020 ident: 523_CR99 publication-title: J. Gastrointestin Liver Dis. doi: 10.15403/jgld-775 – volume: 60 start-page: 325 year: 2014 ident: 523_CR52 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2013.09.015 – volume: 49 start-page: 1904 year: 2009 ident: 523_CR60 publication-title: Hepatology doi: 10.1002/hep.22868 – volume: 107 start-page: 33 year: 2014 ident: 523_CR78 publication-title: QJM doi: 10.1093/qjmed/hct198 – volume: 6 start-page: A82 year: 2009 ident: 523_CR141 publication-title: Prev. Chronic Dis. – volume: 71 start-page: 699 year: 2019 ident: 523_CR84 publication-title: J. Hepatol. doi: 10.1016/j.jhep.2019.05.033 – volume: 16 year: 2018 ident: 523_CR64 publication-title: BMC Med. doi: 10.1186/s12916-018-1149-9 – volume: 39 start-page: 1635 year: 2016 ident: 523_CR50 publication-title: Diabetes Care doi: 10.2337/dc16-1066 |
| SSID | ssj0065539 |
| Score | 2.7213478 |
| SecondaryResourceType | review_article |
| Snippet | Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing... |
| SourceID | swepub proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 60 |
| SubjectTerms | 692/4020/1503/1607/2750 692/700/228 692/700/478 Biomedicine Consensus Statement Epidemiology Fatty liver Gastroenterology Hepatology Humans Liver diseases Medicine Medicine & Public Health Metabolic syndrome Non-alcoholic Fatty Liver Disease - diagnosis Non-alcoholic Fatty Liver Disease - epidemiology Non-alcoholic Fatty Liver Disease - therapy Public health |
| Title | Advancing the global public health agenda for NAFLD: a consensus statement |
| URI | https://link.springer.com/article/10.1038/s41575-021-00523-4 https://www.ncbi.nlm.nih.gov/pubmed/34707258 https://www.proquest.com/docview/2613007461 https://www.proquest.com/docview/2587738204 http://kipublications.ki.se/Default.aspx?queryparsed=id:148057598 |
| Volume | 19 |
| WOSCitedRecordID | wos000712475600002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1759-5053 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0065539 issn: 1759-5045 databaseCode: M7P dateStart: 20180101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ri9QwEB-8O5ED8XG-9u5cIohfNFzaJE3ql-PUW0TOZRGV_VaSNhU56Z7XXf_-mzy65wP2i9CWkrZpwkwmv8xkZgCes7bNLC9airzhqNDMUtMYS7VscuGYyW2I9vn1TE2nej4vZ0nh1qdtlYNMDIK6WdReR36Ue6Drk2Nkxxc_qc8a5a2rKYXGFuz4KAk8bN2bDZK4kDJkEsMZsqQSsUtymmFcH_U4cSnvm4yLaa8ZpeLPiekftPmbpfSvqKJhJprc_d8-3IM7CYOSk8g09-GG6_bg1sdkZd-D21GXR6KL0gP4EFIv47NvBOEiiTFESAyQTaIjJUGxhIt7ghCYTE8mZ-9eE0Nqv1O761c9CW5LXg_5EL5MTj-_fU9TDgZa48pxSXnNGpfpEk9j_KGsVAIpz9tSGOkYqy2WShQViBRdVljEW5KLpmjbwtSMP4LtbtG5J0AaW9gsc5zVXPls7KW3nJeyZZZraXM5gmwgQFWnAOU-T8aPKhjKua4i0SokWhWIVokRvFx_cxHDc2x8-3CgS5WGal9dE2UEz9aPcZB5y4np3GKF70itFEewhFU8jvyw_h0XCvsu9QheDQxyXfmmtryITLSuyAf6TkXneOcqIRHNi_3NjT6A3dx7ZASt0CFsLy9X7incrH8tv_eXY9hScxWuegw7b06ns0_jMEauADeID-I |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEB6VggAJcZRroYCRgBew6sR2nCAhVFFWLd2ueCho34ydOAiBsqXZBfGn-I2M7STlkPatD0iJFOVw4uTL-JvxHACPWF0nlmc1RWw4KnJmqamMpbmsUuGYSW3I9vl-oqbTfDYr3q7Bzz4WxrtV9jIxCOpqXnob-Vbqia4vjpG8PPpKfdUoP7val9CIsNh3P76jyta-2NvB7_s4TcevD1_t0q6qAC1RF1pQXrLKJXmBqzF-UVYqgX3hdSGMdIyVFvdKBD9yH5dkFhmE5KLK6jozJePY7hk4i3JceRcyNRsUvEzKULkMR-SCSuRKXZAO4_lWiwOl8rHQqLx7SywVfw6E_7Db32Zm_8piGka-8ZX_7Z1dhcsdxybb8ae4Bmuu2YDzB50XwQZcirZKEkOwrsObUFoaj30kSIdJzJFCYgJwEgNFCYrdpjIEKT6Zbo8nO8-JIaX3RG_aZUtCWJa3s96Ad6fSs5uw3swbdxtIZTObJI6zkitfbb7wngGFrJnlubSpHEHSf3BddgnYfR2QLzo4AvBcR5BoBIkOINFiBE-Ha45i-pGVZ2_2ONCdKGr1CQhG8HA4jELEzwyZxs2XeI7MleJIBrGJWxF_w-24UNh3mY_gWQ_Ik8ZXPcuTCNqhIZ_IvNv1GbecFhK1FXFn9UM_gAu7hwcTPdmb7t-Fi6mPPgkWsE1YXxwv3T04V35bfGqP74d_kcCH0wbyLzSxahw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bixMxFD6sqywL4mW9VVeNoL5oaGaSzEUQWazFdWvpg8q-xSSTWUSZrjut4l_z13mSzHS9QN_2QWihzCVNZr6c8-XkXAAesrpODM9qithwVBTMUF1pQwtZpcIxnZqQ7fPDJJ9Oi8PDcrYBP_tYGO9W2cvEIKirufU28mHqia4vjpEM684tYjYavzj-Sn0FKb_T2pfTiBA5cD--4_Ktfb4_wnf9KE3Hr969fE27CgPU4rpoQblllUuKEr9a-09uZC5wXLwuhZaOMWvwqMSJgDzIJZlBNiG5qLK6zrRlHNs9B-d9r1hwG5z1WiCTMlQxQ-1cUom8qQvYYbwYtqg0cx8XjQt5b5Wl4k-l-A_T_W2X9q-MpkELji__z8_vClzquDfZi5PlKmy4Zge23nbeBTtwMdowSQzNugZvQslpPHdEkCaTmDuFxMTgJAaQEhTHTaUJUn8y3RtPRs-IJtZ7qDftsiUhXMvbX6_D-zMZ2Q3YbOaNuwWkMplJEseZ5bmvQl96j4FS1szwQppUDiDpX76yXWJ2Xx_kiwoOArxQETAKAaMCYJQYwJPVPccxLcnaq3d7TKhORLXqFBADeLA6jcLF7xjpxs2XeI0s8pwjScQmbkYsrv6OixzHLosBPO3Bedr4ur48jgBeNeQTnHeHPuMvp4TEVYy4vb7T92EL8asm-9ODO7Cd-qCUYBjbhc3FydLdhQv22-JTe3IvTEsCH88ax78AQMhy6g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advancing+the+global+public+health+agenda+for+NAFLD%3A+a+consensus+statement&rft.jtitle=Nature+reviews.+Gastroenterology+%26+hepatology&rft.au=Lazarus%2C+Jeffrey+V.&rft.au=Mark%2C+Henry+E.&rft.au=Anstee%2C+Quentin+M.&rft.au=Arab%2C+Juan+Pablo&rft.date=2022-01-01&rft.issn=1759-5045&rft.eissn=1759-5053&rft.volume=19&rft.issue=1&rft.spage=60&rft.epage=78&rft_id=info:doi/10.1038%2Fs41575-021-00523-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41575_021_00523_4 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1759-5045&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1759-5045&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1759-5045&client=summon |